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ABSTRACT
Proteins are the building blocks of cells in living organisms, and are composed of 
amino acids. The expression of proteins is regulated by the processes of transcription and 
translation. Proteins undergo post-translational modifications in order to dictate their role 
physiologically within a cell.
Not all post-translational modifications are beneficial for the protein or the cell. 
One type of post-translational modification, called carbonylation, irreversibly places a 
carbonyl group onto an amino acid residue, most commonly proline, lysine, arginine, and 
threonine. This modification can have severe consequences physiologically, including 
loss of solubility, loss of function, and protein aggregation.
Carbonylated proteins have commonly been used as a marker o f oxidative stress. 
Oxidative stress has been suggested to play a role in many human disease states, such as 
Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, Parkinson’s Disease, inflammatory 
diseases, and others. Evidence shows oxidative stress to be a contributing factor in the 
progression of aging. Therefore, markers o f oxidative stress, such as carbonylated 
proteins, can provide key information for the development o f valuable therapeutics for 
these conditions. However, they are found in low abundance in samples and require 
enrichment prior to proteomic-based studies.
Currently, affinity chromatography is the chosen method for enriching 
carbonylated proteins in a sample. However, the technique has significant drawbacks,
including a large sample requirement, a large time requirement, the need for 
derivatization, and a high dilution of the sample post elution. This dissertation introduces 
a microfluidic enrichment technique for carbonylated proteins. The technique involves 
the surface modification of a polymer microchip for selective capture o f carbonylated 
proteins. The surface chemistry is verified using different analytical techniques. 
Specificity of the target molecule’s capture is demonstrated using a native protein. The 
capture conditions are optimized experimentally by studying four unique variables.
Lastly, theoretical modeling is performed to determine the conditions that would lead to 
the technique’s failure. It is seen that the technique can selectively capture target proteins 
from a flowing solution, even in the presence of an unoxidized protein. Protein capture is 
most dependent upon flow rate and crosslinker concentration. The flow rates required to 
break the bonds formed between an oxidized protein and the crosslinker exceeds feasible 
levels within a microfluidic channel. The microfluidic enrichment technique provides a 
promising alternative to the current “gold standard” of avidin affinity chromatography. 
The device has promise as a possible protein biomarker discovery tool in the search for 
therapeutic targets in human disease states where oxidative stress has been implicated.
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CHAPTER 1
INTRODUCTION
1.1 Proteins
Proteins are key components o f cells (Vogel, 2011). They serve numerous 
physiological functions, including regulatory activities, enzymatic activity, and structural 
purposes. They are considered an important part of the diet; if  there are too few proteins 
in their nutritional intake, humans can become very ill. Proteins can also serve as toxic 
agents. A few examples of these would be Botulinum toxin A and ricin, some of the 
most potent known toxins.
Proteins are also called polypeptides because their structure resembles a polymer 
chain of peptides. Peptides are small chains of amino acids connected by a peptide bond. 
These molecules are typically less than 10 kDa in molecular weight. The building blocks 
of peptides are amino acids, small organic molecules that form the backbone o f proteins 
(Lusk, 1910). Protein synthesis occurs inside the cell, and their expression is regulated 
by DNA and RNA in processes called transcription and translation. Following the 
translation process, proteins are further modified through processes called post- 
translational modifications that are often used as signaling mechanisms for what the 
protein’s function will be, along with where in the cell the protein will be permanently 
located.
1
1.1.1 Amino Acids Are the Building Blocks o f Proteins
There are over 300 naturally occurring amino acids; however, proteins are usually 
composed of 20 a-amino acids (Uddin et al., 2012). The amino acids share a common 
structure; they have an anime group (-NH2) linked to an a-carbon atom, which is attached 
to a carboxylic acid group (-COOH). The a-carbon contains a hydrogen atom and an R 
group, known as the side chain. The basic structure of all amino acids is shown in Figure 
l - l . The side chain determines most of the chemical features of the amino acids, and 
thus is used as the basis for categorizing them. They are divided into four groups, based 
on the sidechain, 1) non-polar, neutral amino acids, 2) polar, neutral amino acids, 3) 
negatively-charged amino acids, and 4) positively-charged amino acids. The non-polar 
amino acids are glycine, valine, alanine, leucine, isoleucine, methionine, phenylalanine, 
tryptophan, and proline. The polar amino acids are serine, threonine, cysteine, tyrosine, 
asparagine, and glutamine. The negatively-charged amino acids are aspartic acid and 
glutamic acid. The positively-charged amino acids are lysine, arginine, and histidine.
HO
NH
Figure 1-1: The typical structure of an amino acid. The figure above shows alanine. 
The circled group is the sidechain, commonly referred to as an R group
To form a peptide, amino acids are linked together through a peptide bond. A 
peptide bond occurs at the C-terminus of one amino acid and the N-terminus of the next
3amino acid. The reaction results in the release of a water molecule. An example of a 
peptide bond is shown in Figure 1-2. Multiple amino acids can be joined together 
through peptide bonds to form peptides and proteins. The structure, abbreviations, and 
chemical properties of amino acids are included in Appendix A.
OH OHNH
NH.
Figure 1-2: The fonnation of a peptide between two lysines
1.1.2 Transcription and Translation
Protein synthesis is regulated through gene expression by both deoxyribonucleic 
acid (DNA) and ribonucleic acid (RNA) in processes called transcription and translation, 
respectively (Vogel, 2011). Transcription is the process by which a complementary 
strand of RNA is created from DNA. This process takes place within the nucleus of the 
cell. RNA polymerase reads the base pairing of the DNA gene, and places the 
complementary base pair on the RNA molecule. The nucleotides in DNA are adenosine 
(A), guanosine (G), thymine (T), and cytosine (C). Adenosine and thymine are 
complementary bases (A-T), and guanosine and cytosine are complementary bases (C-G). 
RNA uses the same base pairing, except that the nucleotide thymine is replaced with 
uracil (U), which is the RNA complementary base pair for adenosine. Transcription is
the first step in gene expression. It is a multi-step process, resulting in the formation of 
RNA genes.
Most of these RNA are non-coding and serve other purposes inside the cell, but 
one type of RNA, messenger RNA (mRNA), is used for the coding of proteins. After 
mRNA is transcribed, it is transported out of the nucleus and into the cytosol. There, the 
mRNA goes to a ribosome, where the process of translation begins. During the process 
of translation, the sequence of the mRNA gene is read and the corresponding encoded 
peptide is synthesized.
The nucleic acid, mRNA codes for amino acids through a sequence of nucleotide 
triplets, or codons (Frederick and Ibba, 2010). There are 61 codons that specify the 20 
amino acids for protein synthesis. With few exceptions, this mechanism for protein 
coding is universal through all species. The coding always begins at a START codon 
(AUG), which codes for methionine. The coding continues in sequences of three 
nucleotide base pairs until a STOP codon is encountered (UAA, UAG, or UGA). For 
example, the mRNA sequence AAGCCACGC would encode for the three amino acids 
lysine, proline, and arginine (Lys-Pro-Arg), all connected with peptide bonds. Figure 1-3 
shows the three base sequences required for coding the amino acids.
5Second Position
code Amino acid code Aminocode Amino add Amino acid
uuu
STOP STOP
i
Figure 1-3: mRNA codons for transcribing proteins
1.1.3 Post-translational Modifications
Following translation, proteins are moved from the ribosomes to the endoplasmic 
reticulum, where further modification through post-translational modifications occurs. 
These modifications serve various functions. Some of these functions include identifying 
proteins for proteolysis (Shigi, 2012), regulating transcriptional activity (Duquet et al., 
2006), and regulating gene expression (Yang et al., 2010). These examples demonstrate 
the biological relevance of protein post-translational modifications. Figure 1-4 shows an 
image of a cell, with the key areas o f protein processing highlighted. These areas include 
the nucleus (transcription), the ribosome (translation), and the endoplasmic reticulum 
(post-translational modifications).
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Figure 1-4: The image of a cell, with the key locations for protein processing 
highlighted
Other forms of post-translational modifications are induced with a cell is exposed 
to external stresses. Two sources of stressors are reactive oxygen species (ROS) and 
reactive nitrogen species (RNS). Some examples o f ROS include singlet oxygen, 
hydrogen peroxide, and hydroxyl ions. A major source of RNS is NO. These species 
both play critical roles in cell signaling (Klatt and Lamas, 2000), but when unregulated, 
result in oxidative and nitrosative stress, respectively. These stresses can cause extensive 
damage to biologically relevant macromolecules, including membrane lipids, proteins, 
DNA, and lipoproteins.
1.2 Central Hypothesis
One of the key markers of oxidative stress within a cellular system is the 
production of carbonylated proteins. Carbonylation levels are generally associated with 
in vivo oxidative stress conditions (Madian et al., 2011). Carbonylated proteins are 
involved in a large number of human pathologies (Dalle-Donne et al., 2003); therefore,
7these proteins could serve as biomarkers for these diseases. They also have the potential 
to become novel therapeutic targets for the treatment of these conditions. However, we 
do not have enough knowledge to determine the therapeutic or diagnostic capabilities of 
these proteins. One of the factors contributing to our limited understanding of these 
proteins is their low abundance in samples. In order for research to be conducted on this 
sub-proteome, the carbonylated proteins in the sample must be enriched.
Currently, the preferred methodology for carbonylated protein enrichment is 
affinity chromatography, specifically avidin affinity chromatography. Carbonylated 
proteins are derivatized with biotin hydrazide, which has an affinity for carbonylated 
proteins. Avidin affinity chromatography takes advantage of the strong affinity between 
avidin and biotin for positive enrichment of a target. However, this technique has 
significant drawbacks, including a large sample requirement, excessive sample waste, 
and the need for a derivatization step. The process of affinity chromatography is also 
time-intensive. Therefore, the work in this dissertation was organized to develop a more 
efficient way to enrich carbonylated proteins so that their potential as disease biomarkers 
could be assessed. The central hypothesis is that a microfluidic enrichment technique for 
carbonylated proteins, utilizing oxalyldihydrazide as a novel crosslinker, will require less 
sample, produce a smaller elution volume, and be less time-intensive than the current 
enrichment technique of avidin column chromatography.
The technique developed in this dissertation is microfluidic-based. Microfluidic 
techniques require smaller volumes than conventional analytical techniques. The reduced 
sample requirement would allow for easier translation into clinical settings. In addition,
8clinical samples, such as serum and biopsies, are considered very precious, and as such, it
is critical that these samples are not squandered using high-waste analytical methods.
1.3 Dissertation Aims
The three specific aims for this dissertation were as follows:
(i) Develop and test a microfluidic enrichment technique for the selective and 
specific capture of carbonylated proteins. A novel surface modification 
technique, utilizing oxalyldihydrazide, was created for the selective capture of 
carbonylated proteins. Selective protein capture was tested using a model protein, 
cytochrome c, oxidized in vitro. The specificity of the capture mechanism was 
tested using a mixture o f our oxidized protein and a native form (unoxidized) 
protein, bovine serum albumin (BSA).
(ii) Optimize the microfluidic enrichment technique with respect to four variables to 
reduce sample, waste, and time requirements. The four variables were the interior 
post density of the microchip, the concentration of the crosslinker, 
oxalyldihydrazide, the flow rate at which proteins were injected, and the amount 
of time that oxalyldihydrazide was allowed to incubate inside the microchannel 
prior to being washed out of the channel.
(iii) Determine the conditions at which the microfluidic enrichment technique would 
fail. Because of the novelty of the surface modification technique, the binding 
energies of oxalyldihydrazide with poly (methyl methacrylate) (PMMA) and 
amino acid residues were calculated. The results were compared with fluid 
dynamics calculations for determining the conditions in which the microfluidic 
enrichment technique would fail.
91.4 Dissertation Outline
This dissertation consists of six chapters. Chapter 2 provides background 
information about the established knowledge in the field. Topics covered include 
oxidation and oxidative stress, protein oxidation, disease states where protein oxidation 
has been implicated, a more detailed look at carbonylated proteins, history and 
applications of microfluidics and MEMS technology, a discussion about the historic uses 
of oxalyldihydrazide, and some basics about the theoretical techniques used for model. 
The chapter closes with a conceptual example of oxidative stress. Chapter 3 presents the 
development of the microfluidic carbonylated protein enrichment technique that stands at 
the heart o f this dissertation. The optimization of the technique is discussed in Chapter 4. 
Chapter 5 focuses on the theoretical determination of the conditions that would cause the 
enrichment technique to fail. In Chapter 6, general conclusions are presented, including 
future directions for the research and suggestions for improving the method.
CHAPTER 2
LITERATURE REVIEW
2.1 Oxidation and Oxidative Stress
Oxidation is a naturally occurring process in cell development that is used in 
many cellular processes (Zhao and Jensen, 2009). The major source of free radicals in an 
organism is the mitochondria (Zhou et al., 2010; Finkel and Holbrook, 2000; and Balahan 
et al., 2005), although other organelles within the cell, such as peroxisomes, also contain 
oxidizing agents. Figure 2-1 shows the location of free radical stores and sources inside a 
cell. During inflammation, these free radicals are released to oxidize foreign 
macromolecules. Oxidation marks these foreign molecules for degradation by the 
immune system. After these free radicals have completed their jobs, they are inactivated 
by the anti-oxidant system, composed primarily of enzymes (Reed et al., 2008).
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Figure 2-1: Location of the primary free radical stores and sources (peroxisome and 
mitochrondrion) within the cell
If free radicals are not quickly neutralized by anti-oxidants, they begin to oxidize 
macromolecules (lipids, DNA, and proteins) that are neither damaged nor foreign. This 
damage to native tissue is called oxidative damage, with the cumulative effect labeled as 
oxidative stress. Oxidative stress occurs over time (Chang et al., 2000), as an organism is 
exposed to its internal stores o f oxidizing agents and those in its external environment. 
Some physiological effects of oxidation include molecular switch action, enzyme 
inactivation, and triggering of the apoptotic cascade (Alberghina and Colangelo, 2006; 
Krause and Muller, 2010). These consequences become more pronounced as the 
organism ages, as anti-oxidant efficiency decreases (Apelt et al., 2004). To further 
diminish the anti-oxidant system’s efficiency, certain anti-oxidant enzymes become 
oxidized and lose their function. An example such enzyme is superoxide dismutase 
(SOD), whose function is to convert superoxide (O2’) to hydrogen peroxide (H2O2 ) 
(Czapski et al., 2002). Hydrogen peroxide is broken down by catalase into water (H2 O) 
and oxygen (O2 ) (Maehly and Chance, 1954). Oxidative stress has been implicated in
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age-related processes and neurodegenerative diseases, such as Alzheimer’s Disease 
(Nunomura et al., 2006).
2.2 Protein Oxidation
Oxidation is used by the immune system to fight foreign agents, such as in the 
case of bacterial infection. However, when native tissues begin to be oxidized, the results 
are detrimental to the cell. Some consequences of protein oxidation include protein 
misfolding, loss o f function, loss o f solubility, and protein aggregation (Sultana et al., 
2010). There are 35 different ways that a protein can be oxidized, with many residues 
having multiple oxidation products possible (Madian and Regnier, 2010). For a detailed 
look at possible oxidation products, see Appendix.
2.3 Disease States Where Protein Oxidation has been Implicated
2.3.1 Alzheimer’s Disease
Hallmarks of Alzheimer’s Disease (AD) include cognitive impairment and 
dementia. An official diagnosis of AD is not possible prior to autopsy, where 
neurofibrillary tangles (NFTs) are observed. Increased levels of protein dysfunction and 
de-regulation have been seen in cases of AD (Alberghina and Colangelo, 2006; Eckert et 
al., 2010). Oxidative stress is hypothesized to be a contributing factor to the protein 
dysregulation seen in AD. High levels of protein carbonylation, a key marker of 
oxidative stress, have been observed in AD (Dalle-Donne, Rossi, et al., 2003). Recent 
findings suggest a deterioration of the antioxidant system within the brain as a driving 
factor toward the increased oxidative stress levels seen in the temporal cortex of aged 
mice rats (Wang et al., 2010). It is believed that the neuropathology develops many years
before any clinical symptoms manifest (Sultana et al., 2010). However, the link between 
protein oxidation and the physiological manifestations of AD still remains unclear.
2.3.2 Amyotrophic Lateral Sclerosis
A link has been suggested between oxidative stress and other neurodegenerative 
diseases, such as amyotrophic lateral sclerosis (ALS) (Dalle-Donne et al., 2003). ALS is 
a neurodegenerative disease that results in muscle wasting, paralysis, and death, often 
within a two to three year period post-diagnosis. It has been suggested oxidative stress 
plays a key role ALS, and as such, should be treated as a potential therapeutic target 
(Barber and Shaw, 2010). Another study suggests the dysregulation of two key 
antioxidants, glutathione and the enzyme superoxide dismutase-1 (SOD1), results in the 
increased levels of oxidative stress seen in this condition (Schulz et al., 2000; Fischer et 
al., 2012; and Robberecht, 2000). However, the exact pathogenesis o f ALS is poorly 
understood (Robberecht, 2000), requiring much more work prior to actively pursuing 
oxidative mechanisms as a therapeutic target in ALS.
2.3.3 Inflammation
As stated earlier, one of the effects of inflammation is the release o f oxidizing free 
radicals. Organisms use this mechanism as a defense against foreign macromolecules. 
However, inflammation plays a key role in several human diseases (Dalle-Donne et al.,
2003). Some of these conditions include atherosclerosis and autoimmune diseases. A 
study observed that the impairment of vascular reactivity in atherosclerosis was a direct 
result of the reaction between NO and superoxide (O2 ) to form the powerful oxidant 
peroxynitrite (ONOO) (White et al., 1994). Peroxynitrite served as a potent mediator for 
oxidation of lipoproteins, as well as a substrate for (NO), which reduced the capability of
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the smooth muscle to respond to changes in blood flow. The production of ROS in the 
skin causes protein damage in allergic and inflammatory skin diseases (Okayama, 2005). 
A free radical pathway has also been suggested in systemic lupus erythematosus, and 
further studies have implied a unifying theme of oxidative stress, including protein 
oxidation, in the pathogenesis of these inflammatory autoimmune diseases (Kovacic and 
Jacintho, 2003).
2.3.4 Aging
Denham Harman proposed the free radical theory of aging in 1954 (Harman, 
1956). He proposed that irradiation induces cancer, mutations, and aging. One of the 
mechanisms of this irradiation effect was the liberation of free radicals, including OH'. 
The theory was later extended in 1972, adding the suggestion that superoxide was the 
primary free radical from which most others stemmed (Harman, 2006). Mitochondria 
aging effects were added to the theory in 1983. The effects o f tissue exposure to air were 
examined in 1993. Through extensive work over the past 50 years, the free radical theory 
of aging has been established as a valid and useful theory for explaining the aging 
process in organisms (Harman, 2009).
2.4 Carbonylated Proteins
Carbonylation, the most widely accepted form of protein oxidation, has been used 
as a marker for oxidative damage to proteins in vivo (Colak, 2008). Carbonylation is an 
irreversible post-translational modification (PTM) that attaches an aldehyde functional 
group to an amino acid residue (Madian and Regnier, 2010; Suzuki et al., 2010). The 
most common residue targets for carbonylation are lysine, proline, threonine, and 
arginine (Suzuki et al., 2010). While other forms of protein oxidation exist,
carbonylation is the most common, and thus best characterized. Carbonylated proteins 
are often formed in vivo through metal-catalyzed oxidation reactions, one of the primary 
means of enzymatic deactivation within the body (Amici et al., 1989). Typically, when 
proteins are carbonylated, the proteins become more susceptible to proteolytic destruction 
(Davis et al., 1987). Therefore, protein carbonylation can serve as a powerful tool in 
cellular signaling (Wong et al., 2010), but the relationship between carbonylated protein 
marking and destruction are poorly understood.
2.4.1 Detection of Carbonylated Proteins in a Sample
There are techniques for detecting the existence of carbonyls in a protein sample.
The first technique was proposed by Levine et al. (1990) and uses a spectrophotometric 
assay called the DNPH assay. This assay derivatizes carbonyls with 2,4- 
dinitrophenylhydrazine (DNPH) to form a hydrazone bond. Another technique for 
detecting carbonyls is immunochemistry-based (Barreiro et al., 2005). Carbonyls are 
derivatized with dinitrophenyl (DNP), and run through a gel. The gel is transferred to a 
membrane, and the membrane is probed using the anti-DNP antibody. This method can 
be used to visualize the presence of carbonylated proteins within a sample. Total 
carbonyls can also be measured by enzyme-linked immunosorbent assay (ELISA) (Buss 
et al., 1997), slot blotting (Robinson et al., 1999), or immunohistochemistry (Smith et al., 
1998). While DNPH methods of detecting carbonyls are the most prominent, other 
techniques exist. One of these techniques uses sodium borotritide. This technique can be 
used either in solution (Lenz et al., 1989) or as a reaction step prior to gel electrophoresis 
(Yan and Sohal, 1998).
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2.4.2 Identification of Carbonylated Proteins
Proteomics is the study of protein expression in an organism. Proteomics is closely 
related to genomics. Because protein expression is tightly regulated by DNA and RNA 
processes, a change in the genome could result in a change in protein expression. The 
total collection of all proteins within the cell is called the proteome. Each cell, while 
possessing the complete proteome, uses different factors and environment cues for 
determining protein expression (Schulenborg et al., 2006). Therefore, the identification 
of proteins, specifically carbonylated proteins, is important. The field has been greatly 
aided by the cooperation of the scientific community in the creation of online theoretical 
databases, such as SwissPROT and MASCOT. Using mass spectroscopy, structural and 
sequential information can be gathered. This information can even determine small mass 
shifts (on the order o f Daltons) o f individual amino acid residues. This sensitivity allows 
for in-depth analysis o f site-specific post-translation modifications. Through the use of 
proteomics, a lot has been learned about protein expression in disease states (Schulenborg 
et al., 2006; Marcus et al., 2004).
2.4.3 Measurements of Carbonylated Proteins
When using the DNPH method for the determination of carbonyls in a sample, a 
hydrazone bond is formed between the carbonylated proteins and the hydrazine. The 
bond formation is advantageous for measurements because it has a distinctive peak at 
370 nm when analyzed using a spectrophotometer. Beer’s Law, given in Eq. 2-1 below, 
is used for determining the carbonyl relative concentration:
A =  ebc. Eq. 2-1
In Eq. 2-1, A is the absorbance, e is the molar extinction coefficient, b is the 
pathlength, and c is the concentration. Typically, the pathlength and the molar extinction 
coefficient are known. The absorbance is found experimentally, using 
spectrophotometry. Using the known terms, concentration of the carbonyl content can be 
found. The concentration is expressed in the units (nmol carbonyl)/ (mg protein). 
Carbonyl content for individual proteins can be determined using a conventional one­
dimensional (Keller et al., 1993; Yan et al., 1998) or two-dimensional (Nakamura and 
Goto, 1996) sodium dodecyl sulfate (SDS) gel electrophoresis. This step would be 
followed by a Western blot analysis. While this approach is more robust in terms of 
selectivity and specificity than other carbonyl assays, it produces only semi-quantitative 
results (Shacter, 2000).
2.4.4 Metal-catalyzed Oxidation
One of the primary theories for protein oxidation in vivo is metal-catalyzed 
oxidation (MCO). MCO is a site-specific reaction that results in the reduction of Fe (III) 
to Fe (II), producing hydrogen peroxide (H2 O2 ) in the process (Amici et al., 1989). The 
residues most susceptible to MCO reactions are lysine, arginine, threonine, and proline. 
Stadtman and Oliver (1991) suggested that MCO reactions are the primary mechanism of 
increased protein carbonylation in numerous disease states.
2.4.5 Enrichment Requirements and Technology Gap
A limitation on carbonylation studies and a restriction on its use clinically is the 
low abundance of these proteins in a sample. In order to extract useful data, these 
proteins must be enriched and purified. None of the three enrichment methods
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commonly used, affinity chromatography, strong cation exchange (SCX), and 2D- 
polyacrimide gel electrophoresis (2D-PAGE), are ideal.
In affinity chromatography, most commonly, avidin column chromatography 
(Mirzaei and Regnier, 2005; Yoo and Regnier, 2004), carbonyls are derivatized with 
biotin hydrazide and flushed through the column. The high affinity between biotin and 
avidin allow for the labeled proteins to be captured. Elution occurs by rinsing the column 
with excess biotin. Disadvantages of traditional affinity column chromatography include 
the amount of sample needed for the protocol, the amount of reagents needed, and the 
time requirements, the high dilution of the eluted targets, and the need for a derivatization 
step. Recent work has been done to miniaturize the avidin column onto a disposable 
PMMA microfluidic chip (Xia et al., 2012). The study demonstrated a 106-fold reduction 
in the amount of sample needed from the commercially available technology. The use of 
a microfluidic platform also reduced the time needed for the sample analysis. However, a 
derivatization step with biotin hydrazide, a time intensive step, is still required.
Strong cation exchange (SCX) takes advantage of Girard’s P Reagent (GPR).
GPR contains a hydrazide group for derivatization with carbonyls, as well as a quaternary 
amine that can be selected using SCX at pH 6.0. This approach is often used in 
combination with reverse-phase chromatography coupled with tandem mass spectroscopy 
(RPC-MS/MS). While an advantage of this technique is that excess reagent does not 
have to be removed after derivatization, the approach requires a trypsin digestion of the 
GPR-derivatized proteins, adding overall analysis time to the technique (Madian and 
Regnier, 2010).
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In 2D-PAGE, proteins are moved to their isoelectric point (pi) in a pH gradient 
strip. Then, they migrate down the gel, separating by molecular weight (Schulenborg et 
al., 2006). Once separation is completed, selected bands can be excised and analyzed 
using MS. Limitations to this technique include the time needed for analysis and the 
inability to determine if a band is composed of more than one protein while on the gel.
2.5 Microfluidics and MEMS
2.5.1 History
Microfluidics refers to the use of fluidic devices on the spatial scale o f 1 —
100 pm (Ghosal, 2012). The field o f microfluidics is still considered immature. Most of 
the progress in the field has occurred within the last decade. It is difficult to find 
examples of the first “microfluidic” device, but if the spatial definition is recognized, the 
first ink-jet printers, patented in 1951, would qualify as microfluidic devices. The first 
commercially available “lab on a chip” was sold by ALIGENT in 1999. Despite its brief 
history, the field has rapidly emerged to the forefront of scientific exploration. This 
emergence is seen through the number of patents issued related to microfluidics; in the 
nineties, there were only a few. Today, the number o f patents exceeds 350 annually.
Microfluidics is promising for collaborative science because it incorporates principles
from physics, chemistry, engineering, and mathematics. For certain applications, 
including a few discussed in this dissertation, biological considerations must be applied 
as well (Grayson et al., 2004).
2.5.2 Manufacturing Techniques
The simplest microfluidic devices are manufactured relatively inexpensively and 
require little expertise. A microfluidic device can be constructed using two glass
microscope slides, a drill press, double-sided tape, and a cutting device, such as a knife. 
On one glass slide, place a strip o f double-sided tape. Using the knife, the design of the 
channel can be cut into the tape. Two holes are drilled into the remaining microscope 
slide for an entrance and exit reservoir. The microfluidic device is sealed by pressing the 
two glass slides together. For smaller-scale features, a laser could be used to cut the 
chip’s design.
For wet and dry etching of a pattern onto the surface of a microchip, a technique 
called soft lithography, or photolithography, is first employed (Kim et al., 2008). The 
process is shown schematically in Figure 2-2. Photolithography is the process by which 
the mold master is formed, which is then used for the formation of the stamp for creating 
microfluidic channels. This contrasts with the way in which the mold master is created 
for hot embossing. For hot embossing, the mold master is formed through the process of 
micromilling. Typically, the starting substrate is silicon, with a thin layer o f silicon 
dioxide on top. A photoresist can be applied to the substrate. There are two types of 
photoresists, negative and positive. The classification is dependent upon how the 
substance reacts to UV radiation. Following the application of the photoresist, the 
substrate is exposed to UV irradiation. Post UV-exposure, the photoresist is developed.
It is during development that the type of photoresist chosen becomes important. When a 
positive photoresist is exposed to UV radiation, its crosslinks are weakened. UV-exposed 
photoresist is removed during development. Negative crosslinkers, on the other hand, are 
strengthened by exposure to UV radiation. Therefore, the areas not exposed are removed 
during development. The substrate is then etched using wet or dry etching techniques.
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Lastly, the photoresist is stripped from the substrate, and the master can be used for the 
construction of microfluidic devices.
Starting substrate (Si)
NEGATIVE PHOTORESIST
1. Apply photoresist
mPhotoresist
S■ a
n ^ n
3. Develop photoresist 4. Etch substrate 5. Strip photoresist
2. Expose photoresist POSITIVE PHOTORESIST
Figure 2-2: Flowchart for the use of photolithography to create a microfluidic device
Silicon is one of the most popular base substrates used in microfluidic devices. 
Silicon is suitable for a variety of applications, due to desirable mechanical properties, 
including high melting temperature and a high strength-to-weight ratio (Ayon et al., 
2001). However, the substrate requires etching prior to being used as a microfluidic 
device. There are three methods for achieving this, mechanical etching, dry etching, and 
wet etching. Mechanical etching is easier, but cannot generate smooth surfaces. Dry 
etching is effective, but has a low etch rate. Wet etching is the most common form of 
etching for silica-based microfluidic devices (Iliescu et al., 2007). Solutions based upon
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hydrogen fluoride (HF) are used for wet etching. Even though wet etching has a high 
etch rate, one of the trade-offs is less control over the profile due to an isotropic etching. 
Because the substrate is immersed in solution, the etching occurs equally in all directions.
Whereas wet etching involves the immersion of a substrate, such as silicon, to 
etch the desired pattern, dry etching involves the bombardment of the substrate surface 
with high energy molecules (Kameoka et al., 2001; Chun et al., 2006). The high energy 
molecules etch the substrate pattern by colliding with the surface of the substrate.
Another term for dry etching is reactive ion etching (RIE). Dry etching can give higher 
profile control than wet etching, due to anisotropic etching. In this case, the photoresist 
provides additional protection, as the high-energy molecules can only contact the 
substrate where there is no photoresist. The difference results in smoother surfaces for 
dry etching vs. more rounded features in wet etching. However, the tradeoff for 
additional control over the microfluidic profile is the lower etching rate.
Hot embossing is seen as an alternative to the fabrication techniques primarily 
used for silicon or glass-based MEMS (wet and dry etching, discussed above) (Becker 
and Heim, 2000). This technique is a low cost microfabrication technique applied to 
polymer substrates, typically PMMA or polycarbonate (PC). Figure 2-3 shows how hot 
embossing is used for the construction of a microfluidic device. Figure 2-4 shows a 
schematic of a typical hot-embossing system. The two platens in the system (upper and 
lower) are attached to thermocouples, allowing for their temperatures to be controlled 
independently. The metal mold master is placed in contact with the polymer substrate 
and held there to emboss the negative o f the master onto the substrate. The process is 
completed within a vacuum chamber. The high temperatures and contact force used in
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hot embossing make the technique undesirable for use with other microfluidic substrates 
based on silica.
Starting metal mold
1. Mill metal mold to create a master
2. Emboss structure onto polymer surface
Heat and contact force
3. Remove polymer substrate and allow to cool
Figure 2-3: Process for the use o f hot embossing for the creation o f a microfluidic 
device
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Figure 2-4: Schematic of a typical hot embossing system
Polymer-based microchannels are advantageous to life sciences applications. 
Some of the advantages polymers have over glass-based substrates include having a wide 
range of material properties, allowing for the substrate to be optimized to the application. 
In addition, polymers have a high volume fabrication for low material costs (a necessity 
for disposability) and the microfabrication is simplified because of the replication 
methods. In some of the earlier descriptions o f work using hot-embossing, polymer 
based microfluidics were used for chromatographic columns (Arnold et al., 1998), DNA 
concentrators (Christel et al., 1998), DNA separations (Simpson et al., 1998), and 
capillary electrophoresis (Llopis et al., 2007). PMMA and PC are the main two polymers 
used for hot embossing. Tabie 2-1 shows the conditions for using hot embossing on these 
two substrates. PMMA has some advantages over PC, in particular, its lower glass 
transition temperature (Tg) and the lack of toxic chemicals leeching off the substrate. 
Therefore, PMMA is the substrate used for the experiments described within this 
dissertation. Due to the limitations o f micromilling being a mechanical etching
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technique, all microfluidic devices formed by this method will have an inherent 
roughness to them. Table 2-2 shows a side-by-side comparison of the etching techniques 
used in microfluidic device construction.
Table 2-1: Hot embossing conditions for PMMA and PC.
Material Tg (°C)
Embossing
Temperature
(°C)
Embossing 
Force (kN) Hold Time (s)
PMMA 106 120-130 20-30 30-60
PC 150 160-175 20-30 30-60
Table 2-2: Comparison of different techniques for the manufacture of microfluidic 
devices.
Etching
Technique Control
Etching
Speed
Feature
details
Photolithography
required Substrate
Wet
etching Low Medium
Less
detail Yes Silica
Dry
etching Medium Slow
More
detail Yes Silica
Hot
embossing High Fast
Most
detail No Polymer
2.5.3 Applications
Miniaturization and automation are gaining popularity in biomedical research 
labs, primarily because of the reduced analysis times and reduced human participation 
(and consequently, error). An example o f an analytical technique that has undergone 
miniaturization is electrophoresis. Originally, this technique was completed in a gel on a 
benchtop. An advance to this approach was the introduction o f capillary electrophoresis
(CE), which can be coupled to a laser light source for laser-induced fluorescence studies 
(CE-LIF) (Feng and Arriaga, 2008; Feng et al., 2008). This technique combines the 
resolving power of gel electrophoresis with the sensitivity of fluorescence. When 
combined with the automated control of the experiment, this technique has advantages 
over traditional gel electrophoresis (Osiri et al., 2008; Shadpour et al., 2007). Now, 2D- 
micro-CE-LIF (2D-pCE-LIF) is possible and has been reported in the literature (Osiri et 
al., 2008; Shadpour and Soper, 2006; Wang et al., 2012). This technique offers a few 
advantages over CE-LIF. Some of these advantages include smaller size, faster migration 
times, smaller samples, and higher resolving power (Osiri et al., 2008; Shadpour and 
Soper, 2006; Wang et al., 2012). The technique can also be coupled directly to mass 
spectroscopy.
Because of their small volume, reagent requirements, and high-throughput 
capacity, microfluidic devices are excellent for drug screening. Numerous studies have 
been conducted on drug effectiveness inside the chamber of a microfluidic device. One 
study used a microfluidic device to detect bacteria within a sample (Boedicker et al., 
2008). The researchers also analyzed the bacteria’s susceptibility to different antibiotics 
inside the microchannel. Using this methodology, the authors were able to identify the 
antibody sensitivity of methicillin-resistant Staphylococcus aureus (MRSA) using 
multiple antibiotics in a single experiment. Another study created a high throughput 
method to quantify the motility of a parasite (Smout et al., 2010). This study is 
concerned with the pre-emptive detection of livestock parasites prior to human infection. 
The importance of this technique was that it conducted real-time drug screening. This 
screening allowed for the quick identification of drug resistance development in the
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parasite. Microfluidics provides a great platform for pharmaceutical research and drug 
development, including the simple coupling with micro-titre technology for more 
efficient drug discovery techniques (Tolan et al., 2008; Kang et al., 2008).
2.5.4 Microfluidic Cell Capture and Enrichment
In the past decade, microfluidic devices have been used to reduce the reagent 
requirements in cell culture. In one of the studies, a technique was developed to control 
the microenvironment in cell culture (Young and Beebe, 2010). This study was one of 
the first to look at cell biology principles within a microfluidic device. The technique has 
the promise to revolutionize the way cell biology is conducted in the future.
However, at the intersection of cell research and microfluidic technology, most 
attention is paid to the capability of microfluidics to provide a great platform for cell 
capture. In particular, positive enrichment o f cancer cells has been one of the primary 
goals of using microfluidics in cell biology. This enrichment has been accomplished 
using different techniques. One of the techniques was the use of aptamers for selective 
capture o f prostate-specific membrane antigens (PSMA) (Dharmasiri et al., 2009). Anti- 
PSMA aptamers were immobilized onto the surface of a PMMA microchip, and sample 
was loaded into the chip. The analysis was completed in a high-throughput manner, with 
1 mL of solution being analyzed in less than 30 minutes. The PSMA could be released 
from the channel completely intact, allowing for easier analysis post-chip.
Another technique for capturing cells inside a microchip involved the 
immobilization of antibodies onto the surface of a microfluidic chip (Nagrath et al., 2007; 
Adams et al., 2008). These studies analyzed the capture of rare circulating tumor cells 
(CTCs) from a sample. The authors used anti-EpCAM antibodies for the detection of
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CTCs associated with prostate and breast cancer, respectively (Nagrath et al., 2007, 
Adams et al., 2008).
Another technique used electromagnetism as the mechanism for cell enrichment 
on a microchip. One research group used self-assembled magnetic beads for the selective 
capture o f cancer cells (Saliba et al., 2010). The researchers were able to type the cancer 
cells on-chip as well using the technique. All o f these examples demonstrate notable 
advances to cancer biology studies, as well as the high adaptability of microfluidics and 
microelectromechanical systems (MEMS) towards almost any application.
2.5.5 Promise for Novel Diagnostic Tools
Biomedical applications of MEMS (BioMEMS) typically address diagnostic or 
therapeutic goals. Advances in lab-on-chip diagnostic systems and implantable 
therapeutic biomedical microdevices, such as implantable electrodes, have paved the way 
for novel treatments to improve quality o f life (Cheung and Renaud, 2006). In the future, 
these devices will continue to make contributions to the advancement o f health science. 
Even now, the technology exists for the development of “smart” lab on chip technology 
for point-of-care clinical diagnosis (Ahn et al., 2004). These devices are small, portable, 
and have a self-contained power source. This combination makes for simple use in the 
field when access to standard medical equipment is difficult or unrealistic to obtain. The 
addition of renewable power supplies to this technology is being pursued to make it 
available in places like home health and developing countries (Weigl et al., 2008). These 
adjustments would lead to devices that are both minimally-invasive and minimally- 
instrumented. A simplified diagnostic tool reduces both the need for specialized
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equipment for diagnosis and extensive training for analyzing the results. Microfluidics is 
also being applied provide additional novel diagnostic functionality.
The use of MEMS provides a promising platform for protein analysis, especially 
low abundant proteins, where samples may be limited or difficult to obtain (Diercks et 
al., 2009). Microfluidic chips, composed of materials such as glass or silicon, are usually 
simple to construct using basic photolithography techniques. In the last decade, 
polymeric chips have become increasingly popular, due to their versatility and lower cost 
(Becker and Lacascio, 2002; Stachowiak et al., 2003). Particularly, high precision 
micromilling for metal mold master fabrication is desirable for researchers who do not 
have access to extensive lithography based equipment. The combination low cost and 
mass production allows these chips to be disposable, reducing the likelihood of cross­
contamination between samples on a reused chip. Fast analysis, high throughput, and 
low reagent consumption are advantages of BioMEMS over conventional techniques for 
low-abundance samples.
2.6 Oxalyldihydrazide
2.6.1 Historic Uses
Oxalyldihydrazide is a small molecule (MW = 119.6) that has a two carbon 
backbone. Each carbon is double-bonded to an oxygen atom (C=0), and single bonded 
to a hydrazide functional group (-NHNH2 ). Figure 2-5 shows the chemical structure of 
an oxalyldihydrazide molecule. More recently, it has been used in the synthesis of 
biologically active compounds derived from oxalyldihydrazide and complexes it forms 
with different metals (Singh et al., 2009; Aruna and Patil, 1998; Aggarwal and Singh,
2004). It was originally applied in a method for determining copper content within a
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sample, particularly blood (Stark and Dawson, 1958; Beale and Croft, 1960; Kekki and 
Siltanen, 1960). It has also been used in a colorimetric assay to determine phosphate 
levels in drinking waters and soil for environmental monitoring (Salem, 1991).
Even though the molecule had never been used before for microfluidic 
enrichment, there are reasons to believe the molecule would work as an effective 
crosslinker for this project. As demonstrated through the continued use of the DNPH 
assay, carbonyl groups have a strong affinity for hydrazide. Therefore, it was necessary 
to have a hydrazide functional group available for reacting with the carbonyl group of the 
carbonylated proteins. Microfluidic devices, especially polymer-based chips, lend 
themselves well to surface modification (Dharmasiri et al., 2010; Bai et al., 2006; Lee et 
al., 2005). Therefore, proper surface modification would allow the successful 
immobilization of oxalyldihydrazide onto the channel surface. Chapter 3 provides 
experimental support for the process. The crosslinking is verified further in theoretical 
modeling presented in Chapter 5. Figure 2-6 shows a simplistic scheme for crosslinking 
oxalyldihydrazide to the PMMA substrate.
o NH— NH2
Figure 2-5: Chemical structure of an oxalyldihydrazide molecule
2.6.2 Reasons for Choosing Oxalyldihydrazide as the Enrichment Crosslinker
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Figure 2-6: Scheme for immobilizing oxalyldihydrazide onto the surface of PMMA
2.7 Theoretical Modeling
Oxalyldihydrazide has not been used for microfluidic enrichment prior to the 
work presented in this dissertation. It is important to examine the aspects that can lead to 
failure of the enrichment technique. Failure will depend on the energy and critical 
velocity required to break the bond formed between oxalyldihydrazide and PMMA and 
oxalyldihydrazide and amino acid residues of carbonylated proteins. Therefore, density 
functional theory was used to simulate these reactions and calculate the binding energies, 
and Stokes’ law was used to determine the critical velocity is calculated.
2.7.1 Density Functional Theory
Density functional theory (DFT) is based on functions that describe the ground 
state of a multi-electron system by using electron density (Li et al., 2012). DFT is more 
efficient than other theories that involve electronic structures because it reduces the 
number of variables required to complete the calculation. The process is not 
computationally costly and the results are relatively accurate compared to other methods. 
Therefore, DFT is seen as an acceptable method for calculating bonding strengths, 
reactivities, molecular properties, and structural analysis (Bealing et al., 2012). For 
additional details on density functional theory, refer to Kunjumon (2011).
2.7.2 Critical Velocity Calculation
If it is assumed that excessive shear stress will break the bonds between 
oxalyldihydrazide and the protein, then the critical velocity that would cause such 
breakage can be determined using Stokes’ Law. Assuming that the protein, of radius r  is 
immobilized and stationary and exposed to a fluid flow velocity, v, then Stokes Law 
gives the total force on the protein as:
F =  6nr\rv, Eq. 2-2
given by Bell (1978). In the equation, T] is the viscosity of the flowing fluid. A critical 
force can be determined using the binding energy determined from the DFT calculations. 
Because the critical force is directly proportional to the critical flow velocity, the critical 
flow velocity can be calculated. For additional details on Stokes’ law and its application, 
see Bell (1978).
2.7.3 Diffusion of a Protein through a Channel
For a small molecule in a flowing field of velocity v  inside a channel of length L, 
the distance of diffusion inside the channel can be calculated using Eq. 2-3:
Using the protein cytochrome c as the diffusing molecule, a diffusion distance 
inside a microchannel of length 1.5 cm in a flowing velocity o f 0.1666 cm/s can be 
calculated as shown in Eq. 2-4. The diffusion coefficient was taken from experimental 
data presented by Kontturi et al. (1992):
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d =
(1.65 x 10"6)(1.5) Eq.2-4
0.1666
d — 0.0038 cm  or 38 pm. Eq. 2-5
2.7.4 Oxidative Stress Block Diagram
Figure 2-7 shows a flowchart of the oxidative stress process. When an organism 
is exposed to a foreign entity or suffers an injury, an inflammatory response occurs. This 
response triggers the release of ROS into the cytosol, which contributes to oxidative 
stress. This event is transient as ROS activity activates the anti-oxidant system. Anti­
oxidants inactivate the ROS, stopping further oxidative stress. Cumulative oxidative 
events contribute to aging. Aging inhibits the activity of the anti-oxidant system, as the 
enzymes break down over a lifetime. Some enzymes are even oxidized under oxidative 
stress conditions, such as superoxide dismutase (SOD). So, as demonstrated in the block 
diagram, oxidative stress is a cumulative process that expands, even under short, transient 
conditions.
34
Inflam m ation R O S  A c t iv i t y
A nti-O xidan t
System
O xidative Stress
Figure 2-7: Flowchart o f the oxidative stress process
2.7.5 One-compartment Model o f Oxidative Stress in the Cytosol
The effects of oxidative stress will be demonstrated further by analyzing a one- 
compartment model o f anti-oxidant activity inside the cell cytosol. The model is shown 
in Figure 2-8. The model is based on the activity o f catalase, an enzyme that degrades 
hydrogen peroxide into water and oxygen. There are five assumptions for this model.
1. All catalase activity is included in the clearance
2. ROS introduction is treated like a bolus injection
3. No ROS is present in the cytosol prior to the introduction
4. Ke = Kcat of catalase
5. All activity takes place in the cytosol, therefore organelles are not 
considered in this model.
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Figure 2-8: One-compartment model of the cell cytosol
There are three conditions investigated within the model.
1. Physiological conditions: 50 pM H2O 2 , 100 % catalase activity
2. Inflammation response: 100 pM H2O 2 , 100 % catalase activity
3. Aging condition: 50 pM H2 O2 , 20 % catalase activity
The governing equation is given as follows:
The boundary condition, C =  0 at t = 0, will be used because there is no ROS 
present in the system prior to injection, as given by Assumption 3. Applying the 
boundary condition to Eq. 2-6, the equation simplifies to Eq. 2-8:
—  =  - k eC + C08(t), Eq. 2-6
where
D
Eq. 2-7
Eq. 2-8
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With the initial condition C = C0 at t = 0, the solution to the differential 
equation is:
C =  C0e~ket, Eq. 2-9
where, according to Assumption 4, k e =  4 x 107, and where C0 takes different values, 
according to the three stated conditions. The solutions for the equations, with these 
constant values are as follows:
Condition 1:
C =  50e~4xl°7t, Eq. 2-10
Condition 2:
C =  100e"4xl°7t, Eq. 2-11
Condition 3:
C = 50e~8xl°6t. Eq. 2-12
The half-life of the reactive oxygen species is important to consider when looking 
at an oxidative stress situation. Half-life can be calculated from Eq. 2-13:
ln(2)
t y  =  Eq. 2-13
ke
From Eq. 2-13, the half-lives for the stated conditions are:
Condition 1: 17.32 ns
Condition 2: 17.32 ns
Condition 3: 86.62 ns
These results indicate that half-life depends on the enzymatic activity of the anti­
oxidant system, and not the amount of oxidants present. If the activity o f the enzyme is
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maintained, the oxidants will be inactivated before they can do heavy oxidative damage 
to native tissues.
The area under the curve (AUC) is the integral of the concentration, which is 
directly related to oxidative stress. It is calculated from Eq. 2-14:
The two solutions to AUC in Eq. 2-15 are the result o f a manipulation of Eq. 2-13 
that relates t i^ to  k e. Applying Eq. 2-15 to the conditions generates the following
results:
Condition 1: 1250 pJVTns,
Condition 2: 2500 pM ns,
Condition 3: 6250 pM ns.
The model gives valuable insight into the workings of oxidative stress, even 
though it is simplistic in nature. The AUC results tell us that under transient 
inflammation response and in aging conditions, oxidative stress increases at a greater 
rate. These results imply that an organism suffers oxidative stress over the course of its 
life through enzymatic inactivation and through immune responses.
Eq. 2-14
The solution of Eq. 2-14 is Eq. 2-15.
Eq. 2-15
CHAPTER 3
MICROFLUIDIC ENRICHMENT TECHNIQUE DEVELOPMENT
3.1 Introduction
In this chapter, the development o f a novel microfluidic enrichment technique for 
carbonylated proteins will be discussed. In vitro oxidized cytochrome c is used as a 
model protein. Capture is achieved through specific manipulation of the PMMA polymer 
to attach oxalyldihydrazide, a crosslinker specific to carbonyls, to the surface of the 
microchip. In vitro oxidized BSA is used to verify the working of the surface 
modification and in vitro oxidized cytochrome c is used as the target molecule to 
demonstrate the selectivity of the chip. Finally, the study is concluded with analysis o f 
the technique’s ability to capture low abundance target proteins from a mixture 
containing an excess of a large blocking protein. Surface modification of PMMA is 
verified through unique analytical techniques. Surface elemental analysis and roughness 
were examined by X-ray Photoelectron Spectroscopy (XPS) and Atomic Force 
Microscopy (AFM), respectively. Additionally, fluorescence microscopy was used for 
chemical functional groups mapping to verify the presence of desired crosslinkers. This 
work is the first to propose the use of oxalyldihydrazide as a method of carbonylated 
protein enrichment. Use of a crosslinker that is specific to carbonyls eliminates the need 
for derivatization, extensive washing, and preconcentration steps afterwards. In addition,
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this is the first report of carbonylated protein enrichment through coupling the use of a 
crosslinker to a microchip. Portions of this chapter are published in Hollins et al. (2012).
3.2 Materials and Methods
3.2.1 Materials
PMMA sheets were purchased from Goodfellow. 2,4-dinitrophenylhydrazine 
(DNPH), EDTA, HEPES, potassium chloride, magnesium chloride, sodium ascorbate, 
iron(III) chloride, hydrochloric acid, formic acid, N-(3-dimethylaminopropyl)-N’- 
ethylcarbodiimide (EDC), albumin, tetramethylrhodamineisothiocyanate (TRITC-BSA) 
and bovine serum albumin were purchased from Sigma Aldrich (St. Louis, MO). 
Oxalyldihydrazide was purchased from Alfa Aesar (Ward Hill, MA). N- 
hydrosuccinimide (NHS) was purchased from Thermo Scientific (Rockford, IL). 
Naphthalene-2,3-dicarboxaldehyde (NDA) was purchased from Invitrogen (Eugene, OR). 
Cytochrome c was purchased from EMD Chemicals (Gibbstown, NJ).
3.2.2 Metal Catalyzed Oxidation
Bovine serum albumin (BSA) and cytochrome c were dissolved at 10 mg/mL and 
5 mg/mL, respectively, in oxidation buffer (50 mM HEPES buffer, pH 7.4, containing 
100 mM KC1 and 10 mM MgCE). The proteins were oxidized in vitro using metal 
catalyzed oxidation (Amici et al., 1989). Briefly, 30 mL of oxidation buffer containing 
proteins was supplemented with neutral ascorbic acid and FeCl3 , to final concentrations 
of 25 mM and 100 pM, respectively. The mixture was incubated overnight at 37° C in a 
shaking bath. Oxidation was terminated by adding EDTA to a final concentration of 
1 mM. Proteins were aliquoted and frozen at -20° C until use. Proteins were diluted to
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required concentrations prior to experiments. Successful oxidation was confirmed using 
the spectrophotometric DNPH assay.
3.2.3 DNPH Assay of Proteins
Protein oxidation was characterized using the well-established DNPH 
spectrophotometric assay. A 500 pL solution of 2 M HC1 containing 10 mM DNPH was 
prepared. 100 pL of oxidized BSA was added to the solution and allowed to sit at room 
temperature for one hour. After incubation, TCA was added to a final concentration of 
10 % (w/v) and the solution was incubated on ice for thirty minutes to precipitate the 
proteins. The solution was centrifuged for 3 minutes at 11000 rpm and the supernatant 
was discarded. The protein pellet was washed in a solution composed of equal parts 
ethanol and ethyl acetate. After each wash, the solution was centrifuged at 11000 rpm for 
90 seconds and the supernatant was removed. After washing, the protein pellet was 
redissolved in 6 M guanidine. Absorbance was read using a Nanodrop 2000 UV/Vis 
spectrometer at 370 nm to determine the concentration of carbonyls in the oxidized BSA 
model.
3.2.4 Off-chip Protein Loading
Prior to experiments inside the channel, oxidized cytochrome c was labelled with 
naphthalene-2,3-dicarboxaldehyde (NDA), a fluorogenic probe (Pinto et al., 2003). 
Briefly, NDA was dissolved in 100% methanol. 100 pL of 2 mg/mL oxidized 
cytochrome c was placed in a tube. 400 pL of 10 mM borate buffer (pH 9.4) was added 
to the tube, followed by 100 pL of 10 mM KCN dissolved in water. Lastly, 400 pL of 
5 mM NDA/methanol stock was added to the tube. The tube was allowed to incubate for 
30 minutes at room temperature. Following incubation, the sample was rinsed in an
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Amicon Ultra-4 centrifugal filter unit (3,000 MW cutoff) to remove any unbound NDA. 
The rinse was done in 10 mM borate buffer for 20 minutes. The solution was spun down 
to about 200 pL, and the sample was supplemented with 800 pL of borate buffer to give a 
total volume of 1 mL.
3.2.5 Microchip Fabrication
The microchip used in these experiments is shown in Figure 3-1. The bed of the 
PMMA channel has microposts of 100 pm diameter. The depth of the channel is 50 pm, 
and the length of the channel is 12.5 mm. The capture bed is 1 mm wide, containing 
150 microposts. The post-to-post spacing is 150 pm. The surface area available for 
protein capture is 27.6 mm . Because the channel is relatively wide, the posts are 
included to prevent the coverslip from collapsing into the channel during annealing. The 
reservoirs are 1.6 mm in diameter. The chip fabrication process started with the 
micromilling of a mold master. Specifically, the above-mentioned microstructures were 
milled on the surface of a 6.3 mm thick brass plate (alloy 353 engravers brass, McMaster 
Carr, Atlanta, GA) using a high-precision micromilling machine (Kern Mmp 2522, Kern 
Micro-und Feinwerktechnik Gmbh & Co. KG; Germany). A typical milling cycle started 
with a rough milling to prepare an approximate shape for subsequent finishing cut. The 
feed rates were 20 mm/min for a 50 pm drill bit.
Figure 3-1: The microchip used in the studies discussed in this chapter
PMMA sheets (Plexiglas MC, GE Polymershapes, New Orleans, LA) were cut 
into 65 mm diameter discs and cleaned by rinsing with 2-propanol and distilled water. 
After removing residual moisture by placing them in an oven at 75 °C overnight, the 
milled microstructures were pressed into the chips using a commercial hydraulic press 
(PHI Precision Press model TS-21-H-C, City of Industry, CA). A home-built vacuum 
chamber was installed into the hot embossing press to keep ultra-low air pressure 
(< 10 kPa) for complete filling of the mold master. The embossing was performed at a 
force o f 5 kN for 5 minutes at 155 °C. After embossing, injection and collection 
reservoirs were created by using a drill press and a 1/16” black oxide drill bit. For the 
final assembly, a thin PMMA cover plate of 250 pm thickness (Goodfellow, Oakdale,
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PA) was thermo-bonded to the face o f the micropost array chip. For this purpose, the 
microfluidic chip and the cover plates were clamped between two 3” x 3” glass plates 
(McMaster) and placed inside a convection oven at 97 °C for 30 minutes. PEEK tubing 
(800 pm diameter) was attached to enclosed microchips using EPOXY. Chips were 
stored until ready for use for experiments. Prior to experiments, the chips were 
connected to a syringe pump using a LUER connector. The instrumental setup is shown 
in Figure 3-2.
The PMMA surface was modified according to the first two steps shown in Figure
3-3 to produce a PMMA chip containing a crosslinker with hydrazide functions that 
immobilize carbonylated proteins onto carbonyl and ketone moieties. Exposure to UV 
radiation functionalized the PMMA chips with a carboxylic acid group, after which this 
group was modified by the crosslinker oxalyldihydrazide to provide a hydrazine group. 
These groups could then react with the carbonyl group of the proteins of interest to form
PEEK tubing
Microchip
M i c r o C h a n n e lSyringe Pump
Reservoirs
Figure 3-2: Instrumental setup used for loading the microfluidic device
3.2.6 PMMA Surface Modification
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hydrazone linkages. The proteins of interest (BSA and cytochrome c) could then be 
removed from the modified PMMA with formic acid and heat.
CH3
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Figure 3-3: Chemical scheme employed for the enrichment of carbonylated proteins 
within a microchip.
Prior to surface modification, the microchips were cleaned using Micro-90 in 
water and rinsed with 10 % isopropanol and water. Excess fluid was removed under a 
flowing stream of nitrogen and dried in an oven at 70 °C to evaporate any water trapped 
in the microstructures. 250 pm PMMA cover slips were cut to enclose the 
microstructures. Both the microchips and cover slips were then exposed to ultraviolet 
light (254 nm, 15 mW/cm2) for one hour. After UV exposure, the chips and cover slips 
were pressed together for annealing. Afterwards, PEEK tubing was attached to the 
injection reservoir of the chips. A syringe pump was used to pump 100 pL of MES
buffer containing 200 mM EDC and 50 mM NHS through the channel at a flow rate of 
10 pL/min and the solution was allowed to incubate for 30 minutes. After the incubation, 
100 pL of 50 mM oxalyldihydrazide dissolved in MES buffer was flushed through the 
channel at a flow rate of 10 pL/min and allowed to incubate overnight. The channels 
were loaded with proteins the following morning. Solutions of NHS, EDC, and 
oxalyldihydrazide were prepared fresh daily. For experiments conducted on PMMA 
sheets, the same procedure was used for surface modification. Figure 3-4 shows an 
overall flow chart of the surface modification procedure.
Start with Crosslink PMMA Block non-specific
micromilled PMMA with -----» binding sites with
chip oxalyldihydrazide BSA
Clean PMMA and 
dry overnight in oven
Attach PMMA to 
PEEK tubing
Expose PMMA to UV Thermal bond
light PMMA
Load proteins into 
chip and incubate for 
two hours
Verified using 
analytical techniques 
(AFM, XPS)
Verified using both 
analytical/fluorescence 
techniques
Figure 3-4: Flowchart for the enrichment procedure on a microfluidic device
3.2.7 Validation of Surface Chemistry
Surface modification was validated at each step of the procedure using a PMMA 
sheet. Successful UV exposure was demonstrated using water contact angle 
measurements. All modification steps were analyzed using X-ray Photoelectron
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Spectroscopy (XPS) and Atomic Force Spectroscopy (AFM). For XPS and AFM studies, 
PMMA sheets were treated with UV radiation, and then incubated in 1 mL of EDC/NHS, 
oxalyldihydrazide, and proteins. After incubation, each sheet, it was rinsed in dFEO and 
dried under a flowing stream of nitrogen and stored until analysis.
For XPS analysis, all modified and pristine PMMA surfaces were measured by a 
Karatos AXIS ultra-X-ray photoelectron spectrometer using a monochromatic Al Ka X- 
ray source (240 W) and charge neutralization. The sample analyses were performed with 
a 90° takeoff angle and spectral peaks were analyzed using the Kratos software.
AFM studies were performed with a commercial instrument (Nanosurf 
easyScan 2 equipped with a TFT-LCD display). It was operated by a silicon SPM-sensor 
(NanoWorld, Neuchatel, Switzerland) in contact mode with 0.2 N/m spring constant and 
13 kHz response frequency. The ammonium-coated detector is 2 pm thick, 450 pm long, 
and 50 pm wide. All images were recorded in air at room temperature, at a scan speed of
1.4 Hz. The background slope was resolved using the program provided by the 
manufacturer. No further filtering was performed.
Oxalyldihydrazide immobilization within the chip was demonstrated using a 
fluorescent analogue, Alexa 488 hydrazide. Alexa 488 hydrazide was loaded as 
described above, and fluorescence was detected using an Olympus IX-51 Fluorescence 
Microscope with an attached CCD camera. Images were taken using a lOx objective and 
500 ms exposure time. Filter settings for FITC was used for image capture.
3.2.8 Protein Capture
Prior to loading the target protein into the channel, the channel was blocked by 
loading 75 pL of 2 mg/mL BSA at a rate of 5 pL/min. The BSA solution remained in the
channel for 1 hour and then was pushed out using air. Following the blocking,
0.2 mg/mL of NDA-labeled oxidized cytochrome c was loaded into the channel for 
100 minutes at a rate of 5 pL/min using a syringe pump. Solution was collected at the 
collection reservoir every minute for analysis. After the channel was loaded, the chip 
was incubated in the dark for two hours. Protein capture was visualized using 
fluorescence microscopy. For the selective capture study, cytochrome c and TRITC- 
BSA were mixed, with concentrations of 0.2 mg/mL and 0.8 mg/mL, respectively, in the 
same solution and pushed through the channel at 5 pL/min following BSA blocking. 
Solution was collected as described above and analyzed every minute on the 
Nanodrop 3300 fluorescence spectrophotometer.
3.2.9 Protein Elution
Proteins were eluted using 10 % formic acid. The channel was filled with formic 
acid. Formic acid was loaded at a rate o f 10 pL/min. The channel was incubated in an 
oven at 60 °C for 30 minutes. Borate buffer was also heated to 60 °C. After incubation, 
the channel was rinsed with borate buffer at a rate of 5 pL/min to collect the proteins.
The rinsing occurred on a hot plate held at a constant 60 °C. The eluted solution was 
analyzed every minute.
3.3 Results and Discussion
3.3.1 Protein Characterization
Oxidized BSA absorbance was measured with the well-established DNPH 
spectrophotometric assay (Levine et al. 1990). Measuring the absorbance at 370 nm 
yielded a carbonyl concentration of 18 nmol/mg protein. Figure 3-5 shows the results o f 
the DNPH assay. The results obtained from this study verified the placement of carbonyl
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groups on our model protein for further studies. For experiments within the chip, protein 
samples were diluted prior to loading to prevent chip saturation. For XPS and AFM 
studies, protein concentrations of 10 mg/mL were used. Concentrations were determined 
spectrophotometrically using a Nanodrop 3300 Fluorescence Reader. For cytochrome c, 
a large native peak around 400 nm is present, completely covering the carbonyl 
absorbance at 370 nm. Therefore, carbonyl content was not quantified for cytochrome c 
following the metal-catalyzed oxidation process.
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Figure 3-5: Results of the DNPH assay for the determination of carbonyl content in 
oxidized BSA
3.3.2 Water Contact Angle Measurement
Several techniques were used to verify the surface chemistry. First, UV 
modification was confirmed using water contact angle measurements. Carboxyl groups 
on the surface of PMMA make the surface more hydrophilic. After exposing a PMMA 
sheet to UV treatment for twenty minutes, a contact angle o f 46.0 ± 5.7° (n = 3) was
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observed. This angle was compared to a contact angle of 72.2 ± 7.8° (n = 3) for pristine, 
unmodified PMMA. The decrease was not as low as reported values in the literature of 
30° for a similar exposure time (Wei et al., 2005), so UV exposure time was increased to 
one hour for subsequent experiments. The literature results demonstrate a plateau at 
around 40 minutes, so a one hour exposure time was used to generate the expected 
results. A one hour exposure time was chosen to compensate for any differences 
between the setups o f the two UV systems used in this study and the one used in the 
literature study. The difference in the system setup could account for the difference 
between surface contact angles after 20 minutes. Figure 3-6 shows the change in water 
contact angle on the PMMA coverslip after UV exposure.
f
Figure 3-6: Water contact angle between pristine PMMA (a) and UV-modified PMMA 
(b)
3.3.3 Fluorescence Microscopy
To ensure that oxalyldihydrazide would bind to the modified PMMA, a 
fluorescent analogue, Alexa 488 hydrazide, was used in chip. This analogue was used 
because it has the same functional group as the chosen crosslinker. Alexa 488 hydrazide 
was loaded into the closed microchip in the same fashion as described for
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oxalyldihydrazide (detailed in the Methods section). The fluorescence observed in the 
channel after a buffer rinse indicated Alexa 488 hydrazide was immobilized on the 
surface of the microchannel. As a control, Alexa 488 hydrazide was incubated in a 
similar fashion inside a pristine (unmodified) PMMA microchip. After a buffer rinse, no 
fluorescence was observed within the microchannel from the unmodified PMMA. The 
observation is shown in Figure 3-7.
500   I  500
Figure 3-7: Fluorescence microscopy images of an unmodified channel (a) and a UV- 
modified channel (b) after an Alexa 488 hydrazide incubation and rinse
3.3.4 XPS Analysis
XPS studies were conducted on PMMA sheets to verify the chemistry used in the 
surface modification procedure. The samples were prepared modularly, so each new 
modification built upon the last, as indicated in Figure 3-3. The results o f the XPS study 
are shown in Table 3-1. After UV modification, oxygen percentage increased, 
demonstrating the loss of a carbon atom as the methyl group was replaced with a 
hydrogen. The value obtained in this step (0%  = 26.74) matched reported values in the 
literature (0%  = 26.28) after one hour UV exposure time (Wei et al., 2005). After 
oxalyldihydrazide incubation, an increase in nitrogen was observed, corresponding to the
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attachment of the hydrazide functionalities. Oxidized BSA was used to demonstrate 
protein immobilization on the modified surface of PMMA. Protein incubation shows a 
great increase in nitrogen composition. Because the coverslip was rinsed prior to 
completing the next step, the nitrogen increase seen here was attributed to BSA 
immobilization. BSA is a large protein that contains numerous nitrogen atoms in its 
lysine side chains and through its peptide bonds, so the increase in nitrogen content is not 
surprising. The presence of nitrogen after UV exposure can be attributed to leakage o f 
nitrogen present in the air into the sample container. Native BSA was used as well to 
investigate the results of non-specific binding on the coverslip.
Table 3-1: XPS data for the different surface modifications
Sample C (at. %) O (at. %) N (at. %) c/o
Native PMMA 78.78 21.22 0 3.71 .
UV-modified
PMMA 70.52 26.74 2.74 2.64
Oxalyldihydrazide
crosslinked
PMMA
71.80 18.94 4.24 3.79
Oxidized-BSA
immobilized
PMMA
69.97 19.93 10.11 3.51
Native-BSA
immobilized
PMMA
70.50 17.72 11.78 3.98
3.3.5 AFM Analysis
PMMA sheets were prepared as indicated in Section 3.2.6. AFM studies were 
done to calculate the surface roughness of PMMA following each step of the process.
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Because additional molecules were being placed on the surface of PMMA, the roughness 
was expected to increase. The results are shown in Table 3-2. The increase in roughness 
after UV treatment and oxalyldihydrazide immobilization was small, consistent with the 
small size of the molecules placed on the surface. A great increase is observed following 
oxidized BSA incubation. Because of the size o f BSA (66 kDa), a large increase such as 
this could be expected. A similar increase was observed with native BSA, though not as 
large.
Table 3-2: AFM results for the different surface modification stages
Stage Area Surface Roughness (RMS)
Native PMMA 4.03 nm
UV-modified PMMA 6.41 nm
Oxalyldihydrazide-crosslinked PMMA 9.87 nm
Oxidized BSA-immobilized PMMA 31.5 nm
Native BSA-immobilized PMMA 
(Control) 20.5 nm
These experiments were conducted on the PMMA sheets, which were used as 
received from Goodfellow. Within the microchip, it is important to consider the effect 
that the micromilling process will have on the surface roughness of the microfluidic 
channel. Any milling marks present on the mold master will be transferred to the 
microfluidic chip, since hot-embossing is a technique capable of replicating structures to 
the nanometer range. Over time, the characteristics of the mold master can change, and 
introduce inconsistencies in the microstructures. To minimize this problem, a two-fold 
strategy was employed. First, because of its excellent machining characteristics, brass
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was used as the mold master. Secondly, the mold master milling was completed using 
two steps, removal of the bulk material using a large diameter (500 pm) bit, followed by 
use of a smaller milling bit for the finer structures o f the design.
3.3.6 Protein Capture
NDA-labelled oxidized cytochrome c (0.2 mg/mL) was loaded into the channel 
and allowed to incubate for two hours. During the loading process, the solution that 
flowed through the channel was collected for spectrophotometric analysis. NDA is a 
fluorogenic molecule that is only fluorescent after it has reacted with a primary amine 
group. Because we use BSA as a blocking protein for the channel, it is necessary to 
remove any unbound NDA prior to loading it into the channel. This removal prevented 
any blocking BSA from being labelled with the NDA and altering the results obtained. 
The amount of oxidized cytochrome c captured in the microchip could be quantified 
using a Nanodrop 3300 spectrophotometer. Figure 3-8 shows the protein amounts 
collected each minute. The total protein mass captured during the continuous injection 
period of 100 minutes is 7.5 pg. The plateau seen in Figure 3-8suggest binding of the 
target molecule to the reactive sites on the surface of the microchannel, allowing for less 
binding to occur as more proteins are exposed to the chip, indicating a move toward 
saturation. Chip saturation occurs when all the available reactive sites for binding are 
consumed on the surface of the modified PMMA. Protein capture is also demonstrated 
qualitatively using fluorescence microscopy. The capture is shown in Figure 3-9.
Capture is expected to be linear throughout the experiment, but the results indicate an 
area of non-linearity at the beginning of the study. A potential explanation for the non- 
linearity could be that the chip does not capture proteins during the initial loading phase,
54
when the solution is first exposed to the crosslinkers. As the chip becomes filled with 
fluid, capture improves because there are not two phases present against the crosslinkers.
In the fluorescence study, while not shown here, there are controls that could be 
used to verify the capture of the targeted proteins. One example would be to compare the 
channel following capture to a channel that does not have any proteins inside of it. 
Another control would be to not conduct multiple steps o f the surface modification 
procedure, such as not doing a UV-modification step or crosslinking with 
oxalyldihydrazide, and comparing the fluorescence within the channels.
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Figure 3-9: Fluorescence microscopy of cytochrome c capture following protein 
loading and excess fluid removal
3.3.7 Protein Elution
Formic acid and heat were used to elute the proteins. Fonnic acid breaks 
hydrazone bonds when incubated at an elevated temperature (Roe et al., 2007). After 
thirty minutes of incubation at 60 °C, the channel was rinsed with borate buffer. Since 
the proteins were labelled and injected into the channel using borate buffer, this same 
medium was chosen to collect the proteins during elution. The solution was collected 
from the microchip and analyzed using the Nanodrop 3300. All the proteins injected into 
the channel were eluted within three minutes of continuous injection of borate buffer.
The results are shown in Figure 3-10. The total amount o f protein eluted was 8.5 pg. 
When the amount of protein eluted is compared to the amount determined to be captured, 
a cumulative elution efficiency of 113 % is obtained. The cumulative elution efficiency 
was calculated as the percentage of proteins eluted from the channel and divided by the
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total amount available for elution. For the data shown in Figure 3-10 as an example, after 
one minute, 3.5 pg of the 7.5 pg captured is eluted, resulting in a cumulative elution 
efficiency of 46 %. For each additional minute, the total o f all the proteins eluted are 
summed together and divided by the total protein amount available. The additional 
proteins found in the elution could have been inside the injection tubing when injection 
finished. Because the proteins are allowed to incubate for two hours following injection, 
any proteins still in the tubing could diffuse into the chip and react with any available 
surface. It is proposed that this action added the additional 1 pg of protein to the elution, 
therefore yielding a cumulative elution efficiency in excess of 100 %.
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Figure 3-10: Protein elution per minute from the microfluidic device
The elution of the proteins increased the concentration of proteins available from 
the original stock solution (0.2 mg/mL). The new concentration, using the 15 pL 
required to elute all the proteins, is 0.53 mg/mL, an increase of 265 %.
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3.3.8 Protein Mixture Results
To determine the specificity o f the chip for oxidized proteins, oxidized 
cytochrome c, labelled with NDA, was mixed in low abundance (1:4) with TRITC-BSA 
and injected into the chip. The results of that study are shown, in Figure 3-11. The chip 
was able to capture 40 % of oxidized proteins over the 100 minute injection period, 
whereas only 5 % of the unoxidized protein was captured. These results show that, even 
in low abundance, the chip is highly specific to oxidized proteins. The 5 % capture 
observed from the unoxidized protein (TRITC-BSA) could have been the result of some 
proteins displacing BSA, which was used to block the chip. The results found for the 
non-specific binding was confirmed by loading TRITC-BSA into a modified channel. 
These results are seen in Figure 3-12.Without blocking, TRITC-BSA is captured within 
the chip; after blocking, the capture is significantly lower. These results support the 
reasoning that TRITC-BSA is displacing BSA within the channel and indicate the 
necessity of blocking the chip prior to enrichment studies in order to increase the chip’s 
discrimination of oxidized and unoxidized proteins.
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■ Oxidized protein
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Figure 3-11: Results o f the protein mixture study
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Figure 3-12: Non-specific binding with and without prior blocking of the channel with 
BSA
3.3.9 Discussion
The effect of fluid dynamics on the ability of the microchip to capture targets is 
an area of future work. Flow rate studies can be used as a variable for optimizing protein 
capture efficiency. While a faster flow rate would expose the modified surface to
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additional proteins during the loading process, the effects o f shear stress on the 
crosslinker, oxalyldihydrazide, would have to be considered. To date, no studies have 
been done on the strength of the bond formed between oxalyldihydrazide and the 
carboxyl-labelled PMMA surface or the hydrazone bond formed with the carbonyl of the
protein. Excessively high flow rate could break the links that capture the target 
molecules, but excessively low flow rate will increase the time of the experiment. 
Therefore, flow rate needs to be optimized in future work.
Another area of consideration is the interior geometry of the chip. In this 
experiment, we used a low-density micropost interior. For future studies, the density of 
the microposts can be altered to determine if capture efficiency has a dependency on the 
interior geometry.
The method presented in this chapter has several advantages over the 
conventional avidin chromatography technique for carbonylated protein enrichment.
One, there is no need to derivatize samples prior to enrichment for the technique. Even 
though the sample was derivatized with fluorogenic agents, it is not necessary if  the 
device is being used as a preconcentrator. Chromatography requires the sample be 
derivatized with biotin, a process that is very time-consuming, including 12 hours for 
dialysis to remove unbound hydrazide. The technique presented here takes 4.5 hours 
from protein loading to elution. Also, in order to be effective, avidin chromatography 
needs at least 2.5 mg of protein, whereas this technique can enrich any amount of protein. 
The use of a microfluidic chip greatly reduces sample waste and protein elution occurs in 
a very small volume, greatly increasing the concentration of low abundance targets. 
Chromatography requires a high volume of elution solution, diluting even further an
60
already very dilute sample. Also, when the targets are released from the microchip, they 
are readily available for future studies, with the carbonyl available for additional labeling 
if  necessary. In standard affinity chromatography, should the carbonyl need to be 
relabeled post-elution, the hydrazone bond between biotin and the carbonyl would need 
to be broken.
It is important to consider that the elution procedure for this technique is harsh for 
biomacromolecules such as proteins. Because of the increased temperature and acidic 
conditions for reversing the bond, the protein being captured will be denatured. In 
studies where the proteins are being identified, denaturing the protein will not be a 
concern. However, for applications in which the protein’s function needs to be 
conserved, this technique may not be the best approach for protein enrichment.
3.4 Conclusions
In this chapter, proof of principle of a microfluidic enrichment technique for 
carbonylated proteins using oxalyldihydrazide as an immobilized crosslinker was 
presented. The preliminary results shown in this chapter demonstrate that the 
methodology is effective at capturing and eluting carbonylated proteins. Based on the 
new concentration of the proteins following elution, the microdevice has a 
preconcentration factor of 2.65. An area of work that remains is optimizing the capture 
process. Key areas for optimization include the flow rate at which proteins are injected 
into the channel and the effect of density on the capture efficiency of the chip. The 
optimization of these conditions, along with two other key variables, will be discussed in 
the following chapter.
CHAPTER 4
TECHNIQUE OPTIMIZATION
4.1 Introduction
In Chapter 3, a proof-of-principle microfluidic technique for enriching 
carbonylated proteins was demonstrated. Capture, enrichment, and elution could be 
achieved using the novel methodology. The procedure is capable of enriching proteins 
on the microgram (pg) level, and the sample is eluted at a much higher concentration than 
what is possible using the commercial standard. Specificity toward the target of interest 
when a mixture o f oxidized and unoxidized proteins was injected into the channel was 
also shown. This chapter examines the effects of micropost density inside the 
microchannel, concentration of the crosslinker, flow rate, and incubation time of the 
crosslinker on capture within the microfluidic platform. It is shown that micropost 
density has little effect on capture and that shorter incubation periods result in capture 
that is marginally better than longer incubation times. In addition, slower flow rates 
result in significantly better capture and protein capture follows a parabolic curve with 
crosslinker concentration.
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4.2 Materials and Methods
4.2.1 Materials
PMMA sheets were purchased from Goodfellow. EDTA, HEPES, potassium 
chloride, magnesium chloride, sodium ascorbate, iron (III) chloride, and N-(3- 
dimethylaminopropyl)-N-ethylcarbodiimide (EDC) and bovine serum albumin (BSA) 
were purchased from Sigma Aldrich (St. Louis, MO). Oxalyldihydrazide was purchased 
from Alfa Aesar (Ward Hill, MA). N-hydrosuccinimide (NHS) was purchased from 
Thermo Scientific (Rockford, IL). Naphthalne-2, 3-dicarboxaldehyde (NDA) was 
purchased from Invitrogen (Eugene, OR). Cytochrome c was purchased from EMD 
Chemicals.
4.2.2 Channel Construction
The microchannels were formed using a nickel mold master and hot embossing. 
The process is described in detail in the previous chapter. The two microchip designs 
used in the study are shown in Figure 4-1. Both channels are 12.5 mm long and 1 mm 
wide. The first channel, shown on the left, contains 150 microposts, with a post-to-post 
spacing of 150 pm, measured edge to edge. This channel was used in the studies 
discussed last chapter. The second channel, shown on the right, contains 465 posts, with 
a post-to-post spacing of 100 pm, measured edge to edge. Following hot embossing, the 
PMMA chips and PMMA sheets were washed and dried in an oven at 65 °C overnight. 
Following drying, the chip and PMMA coverslips (250 pm thickness) were exposed to 
UV light (254 nm, 15 mW/cm ) for one hour to place carboxylic acid residues on the 
PMMA surface. The chip and cover sheet were pressed together using 3” x 3” glass 
plates and annealed at 97 °C for 30 minutes. PEEK tubing (800 pm diameter) was
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attached to the reservoirs using marine EPOXY. The experimental setup is the same as 
shown in Figure 3-2.
LTU-0331 2012^04/27 09:20 L 02.3 x120 500um  LTU-0333 2012/04J2? 09:40 L 02.1 x120 SOOum
Figure 4-1: The two channel designs used in the optimization experiments. The 
channel on the left is the same channel used in the experiments in the last chapter. The 
channel on the right has a higher post density. The scale bar is 500 pm
4.2.3 Surface Modification
After the EPOXY was allowed to fully cure, 100 pL of MES buffer containing 
200 mM EDC and 50 mM NHS was loaded into the channel using a syringe pump at a 
rate of 10 pL/min to activate the carboxylic acid functional groups on the surface of the 
PMMA microchip. The PEEK tubing was connected to the syringe pump using a LUER 
connector. The solution was allowed to incubate within the channel for 30 minutes.
After incubation, 100 pL of oxalyldihydrazide, dissolved in MES buffer, was loaded into 
the channel at a rate of 10 pL/min and allowed to incubate. Air was pushed through the 
channel after the incubation to remove unbound hydrazide. The channel was filled with 
2 mg/mL BSA to block non-specific binding at a rate of 5 pL/min. The BSA was 
allowed to incubate for one hour, followed by a 100 pL rinse with 10 mM borate buffer 
at a rate of 10 pL/min. Finally, air was pushed through the channel to remove the borate
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buffer and the proteins were loaded into the channel. Fresh solutions of EDC/NHS and 
oxalyldihydrazide were prepared daily.
4.2.4 Off-chip Protein Labeling
Cytochrome c (5 mg/mL) was oxidized in vitro using metal catalyzed oxidation 
(MCO). Oxidized cytochrome c was diluted to 2 mg/mL in 100 % methanol and placed 
in freezer until experiments. A stock solution of 5 mM NDA dissolved in methanol was 
prepared and stored in refrigerator protected from light. The stock solution was used 
within a week. Prior to loading into the channel, proteins were labeled with the 
fluorescent tag NDA. 100 pL of oxidized cytochrome c was placed in a small centrifuge 
tube. Into the tube was added 400 pL of 10 mM borate buffer (pH 9.3), 100 pL KCN, 
and 400 pL of NDA, in that order, giving a total sample volume of 1 mL. The tube was 
allowed to incubate for 30 minutes in the dark. Following incubation, the sample was 
loaded into an Amicon Ultra-4 centrifugal filter unit (3000 MW cutoff) to remove 
unbound NDA. Two rinses occurred in 10 mM borate buffer at a speed of 4500x g for 
20 minutes, followed by a final spin down to about 200 pL at the same conditions. The 
sample was supplemented to a total volume of 1 mL with 10 mM borate buffer. 
Fluorescence measurements using the Nanodrop 3300 photospectrometer were taken to 
verify the presence of the fluorescently-tagged proteins within the sample. The proteins 
were then loaded into the channel.
4.2.5 Interior Geometry Studies
Protein capture was measured using the two different interior geometries shown 
in Figure 4-1. Proteins were loaded into the channel at a flow rate o f 5 pL/min. Proteins 
were loaded through the PEEK tubing and collected at the exit reservoir of the chip using
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a pipettor. The flowthrough solution was collected every minute and analyzed using the 
Nanodrop 3300. Both channels were surface modified on the same day using the same 
oxalyldihydrazide, EDC/NHS, and BSA solutions.
4.2.6 Oxalyldihydrazide Concentration Studies
Oxalyldihydrazide concentration was varied to assess its impact on protein 
capture. The concentrations used were 5 mM, 10 mM, 25 mM, and 50 mM. The protein 
was loaded and collected as described above. The oxalyldihydrazide concentrations were 
serially diluted from the same sample of 50 mM. All channels were surface modified on 
the same day using the same solutions. Experiments were performed in the lower density 
channel shown in Figure 4-1.
4.2.7 Flow Rate Studies
Different flow rates were tested to determine protein capture. The flow rates used 
were 5 pL/min, 10 pL/min, and 20 pL/min. The concentration of oxalyldihydrazide was 
25 mM. Experiments were completed using the lower density channel shown in Figure
4-1. All channels were surface modified the same day using the same solutions. Proteins 
were loaded and collected as described above.
4.2.8 Oxalyldihydrazide Incubation Studies
Incubation time for oxalyldihydrazide following chip loading was varied to 
determine protein capture. The incubation times chosen were 1 hour, 4 hour, and 
overnight (16 hours). The protein loading flow rate was 5 pL/min. All other conditions 
from the flow rate study were applied.
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4.2.9 Statistics
For data collected from the flow rate and crosslinker incubation time experiments, 
a two-tailed, equal variance Student’s t-test was used for statistical analysis with a 
p  < 0.05 being considered statistically significant.
4.3 Results
Interior geometry of the microfluidic chip was varied to investigate the effects on 
protein capture. Figure 4-2 shows the results o f these studies. After 40 minutes of 
continuous protein flow, both channels capture about 5 pg of proteins. The capture 
occurs at a steadier rate using the lower density channels, whereas the higher density 
channels begin to capture later, but over time achieve equality with the lower density 
channel.
4.3.1 Interior Geometry Studies
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Figure 4-2: Results of the interior geometry studies
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4.3.2 Oxalyldihydrazide Concentration Studies
The effects of oxalyldihydrazide concentration on protein capture were studied. 
The results are shown in Figure 4-3. The highest capture is observed at an 
oxalyldihydrazide concentration of 25 mM. Both 5 mM and 10 mM resulted in lower 
capture, while using 50 mM resulted in the lowest capture efficiency. After 40 minutes, 
both 5 mM and 50 mM are decreasing their positive slope, suggesting a move toward 
saturation, whereas 10 mM and 25 mM are still increasing.
♦ 5 mM  oxalyldihydrazide 
concentration
A 10 mM ox alyldihy drazide 
concentration
•  25 mM oxalyldihydrazide 
concentration
■ 50 mM oxalyldihydrazide 
concentration
Figure 4-3: Results of the oxalyldihydrazide concentration studies
4.3.3 Flow Rate Studies
Protein capture for different flow rates is shown in Figure 4-4. Each channel had 
the same mass o f proteins (40 pg) injected into it. Protein capture per minute was 
normalized to allow for easier comparison. The highest normalized capture occurs at 
5 pL/min. Capture decreases with each faster flow rate. Capture is significantly higher 
under 5 pL/min flow vs. the other two flow rates (10 and 20 pL/min: p  = 5.8 x 10'7 and
10 20 30
Time {min)
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7.67 x 10'5, respectively), whereas a significant difference was not observed between the 
10 and 20 pL/min flow rates.
■ 5 ul/min
■ 10 ul/min
■ 20 ul/min
Figure 4-4: Protein capture as a function of flow rate. The bars represent the average 
normalized protein capture with bars representing a 95 % confidence interval (mean ± 
95 % Cl)
4.3.4 Oxalyldihydrazide Incubation Time Studies
Lastly, oxalyldihydrazide incubation times were varied to enhance protein 
capture. The results are shown in Figure 4-5. As with flow rate, protein capture per 
minute is normalized to allow for comparison between the groups. Capture efficiency 
was slightly lower for the larger oxalyldihydrazide incubation times, but the results were 
not statistically significant between the groups.
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■ 1 hour
■ 4 hour
■ Overnight (16 hour)
Figure 4-5: Results of the oxalyldihydrazide incubation studies
4.4 Discussion
It was expected that additional microposts would increase the surface area for 
hydrazide modification and therefore, protein capture. However, it was observed that 
capture was not enhanced in a higher density channel. It is suspected that the capture is 
not different because of the way UV light is exposed to the chip. The chip is directly 
underneath the UV light source when carboxylic acid groups are placed on the surface. 
The posts are parallel to the UV light source; therefore, the sides o f the posts are not 
exposed to UV light. This lack of exposure prevents carboxylic acid groups from being 
generated there. Therefore, the area available to capture proteins is completely dependent 
upon the area of the floor of the channel and the coverslip above the channel (Figure 4-6). 
The two designs do not differ much in this available area, so it is not surprising to see 
such a result. Because the amount of capture was similar between the two channels, the
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lower density channel was used for future experiments because it had a smaller pressure 
drop. A potential method for overcoming the lack of exposure for the sides o f the 
microposts would be to use fiber optics. The sides o f the posts could be modified by 
shining a UV fiber optic parallel to the walls o f the channel and perpendicular to the 
microposts. This approach, while not allowing for total activation of the sides o f the 
posts, would increase the amount of UV activation on the posts compared to the current 
UV exposure technique.
Figure 4-6: Approach of UV light to the microchip makes activation of the sides o f the 
microposts difficult
For the proof-of-principle studies detailed in the previous chapter, an 
oxalyldihydrazide concentration of 50 mM was used. The concentration of 
oxalyldihydrazide was varied in order to determine whether reagent usage could be 
optimized within the enrichment protocol. The results show that an oxalyldihydrazide 
concentration of 25 mM was optimal for protein capture. The observation that both 
5 mM and 10 mM concentrations of oxalyldihydrazide had higher capture efficiency than 
a 50 mM concentration was unexpected. Upon further investigation, it is seen that 
oxalyldihydrazide is supersaturated at a concentration of 50 mM when dissolved in MES
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buffer. This is the only concentration at which it is not completely dissolved in solution. 
The undissolved oxalyldihydrazide may interfere with the binding capacity o f the chip. 
This interference could occur as undissolved hydrazide settles onto carboxylic acid 
residues, but does not react with the functional group. These particles are pushed out 
during the evacuation step, leaving unreacted carboxylic acid groups which are then 
blocked with BSA. This process would reduce the capture ability o f the chip. The 
parabolic capture curve seen from the oxalyldihydrazide studies support this hypothesis, 
shown in Figure 4-7.
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Figure 4-7: Parabolic nature of protein capture in relation to the concentration of 
oxalyldihydrazide
For the flow rate experiments, it was decided that the best approach would be to 
inject the same amount of mass into each channel. This approach would prevent a mass 
bias from being introduced into the experiment, where additional proteins are captured at 
faster flow rates because an additional amount of protein mass flows into the channel. 
This scenario would have been the case if each flow rate was allowed to be injected for 
the same amount of time. Additionally, by using normalized protein capture per minute
in the data analysis, the potential for mass bias was prevented even further. Protein 
capture was normalized by dividing the fluorescence value obtained from the solution 
collected at the collection reservoir by the fluorescence value collected from the original 
sample prior to loading it into the chip. Normalized protein capture differed significantly 
between the lower flow rate and the other flow rates used in the study. The greater 
capture is attributed to the targets being in contact with the sample for a longer period of 
time. This increase in contact time would result in a higher chance of the bond being 
formed, and thus, a better capture efficiency. Indeed, when cell capture studies were 
completed inside a microfluidic channel, a similar phenomenon was observed, as capture 
increased linearly with the amount of time the cells were allowed to remain in contact 
with the aptamers (Phillips et al., 2009). Another study looked at microfluidic negative 
enrichment of target cells. Their results demonstrated higher sample purity at lower flow 
rates, indicating that lower flow rates result in higher capture in microfluidic 
environments (Li et al., 2011). The difference between the 10 and 20 pL/min flow rates 
was not significant. However, it is believed that the difference would have been 
significant if the 20 pL/min flow rate had more samples. An increase in sample points 
would have allowed the data to be in closer agreement with the central limit theorem’s 
minimum requirements.
An effort was made to prevent a mass bias in this study by loading the same mass 
o f proteins through the chip. If all studies were conducted for the same amount of time, 
the expectation that lower flow rates would result in higher mass capture would be 
counter-intuitive. One would tend to expect a higher capture at faster flow rates because 
of the increased mass exposed to the functionalized surface.
73
The results also lead to the possibility o f a misconception being formed 
concerning protein capture. Based on the results seen here, it would be expected that as 
the flow rate moves slower, the capture efficiency would proceed to 100 %. However, 
protein stability needs to be considered. Slower flow rates would result in longer 
experimental times. Increasing experimental time also increases the likelihood of the 
protein becoming more labile. Also, the detection methodology used in these studies, 
fluorescence, is sensitive to time as well. Therefore, the longer the experiment occurs, 
the less observable the fluorescence intensity becomes. As fluorescence intensity 
decreases, overestimation of the protein capture within the microchannel would occur.
Lastly, a study on the amount of time oxalyldihydrazide was incubated inside the 
channel was completed. The purpose of this study was to determine if  shorter 
incubations had a negative effect on protein capture. In previous studies, 
oxalyldihydrazide was allowed to incubate overnight. This study was conducted to 
determine if the total time for enrichment could be reduced. It was seen that a reduction 
in incubation time resulted in a slight increase in capture efficiency. However, the 
increase is not statistically significant. In fact, the cumulative capture percentage 
difference between a one hour incubation and an overnight incubation is roughly 3 %, or 
3 pg per 100 pg of proteins injected. When taking into account that the system’s dead 
volume can easily contain 3 pg, this difference is statistically insignificant. However, 
lack of statistical significance does not imply the data is not meaningful. On the contrary, 
these results allow for time optimization of the enrichment protocol, as it is now known 
that the chip is ready for capture after only one hour o f oxalyldihydrazide incubation.
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4.5 Conclusions
In this chapter, a series o f experiments were presented with the intention of 
optimizing protein capture using the microfluidic technique. Micropost density and 
oxalyldihydrazide incubation time only marginally affected protein capture. 
Oxalyldihydrazide concentration and flow rate significantly affected capture efficiency. 
Following the optimization studies, sample size, perfusion time, and reagent consumption 
were reduced. A critical consideration of the methodology is the determination of the 
point-of-failure. In particular, it is important to analyze the conditions at which the chip 
would not be effective at enriching the target carbonylated proteins. The theoretical 
modeling for this determination is discussed in the next chapter.
CHAPTER 5
MODELING THE POINT OF FAILURE
5.1 Introduction
In Chapter 3, a novel microfluidic enrichment technique was developed for the 
capture, enrichment, and elution of carbonylated proteins. The technique had a 
preconcentration factor of 265 %. In Chapter 4, progress continued on making this 
technique an attractive alternative to the commercially available avidin chromatography 
technique currently considered the gold standard in enrichment technology. Four 
variables were studied for optimization of the process. The optimization of the process 
resulted in a reduction of sample, reagent, and time requirements.
It is important to determine experimental conditions that would cause the 
technique to fail. Failure is defined in this sense as conditions that would result in 
reduced ability for the methodology to enrich carbonylated proteins. In this chapter, 
theoretical modeling is used to analyze experimental conditions that would result in 
failure. Density functional theory is used to determine the binding energies of the 
oxalyldihydrazide molecule to both the UV-modified PMMA and to the amino acid 
residues lysine, proline, arginine, and threonine. Cytochrome c is used as the protein 
model for protein capture. The results obtained from density functional theory allow for 
the calculation of a critical force. This critical force is used in Stokes’ law to determine a 
critical velocity for proteins. Based on these calculations, the experimental conditions
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leading to failure are identified. It is seen from the results that failure o f the microfluidic 
device will most likely not be a result of the bonds breaking, as the critical velocities 
calculated are not feasible within a microfluidic environment.
5.2 Methods
5.2.1 Chip Dimensions
The microchannels were formed using a nickel mold master and hot embossing. 
The process is described in Chapter 3. The microchannels used for modeling were 
described in Chapter 4. Refer to Figure 4-1. Both channels are 12.5 mm long and 1 mm 
wide. The first channel, shown on the left, contains 150 microposts, with a post-to-post 
spacing of 150 pm, measured edge to edge. The post diameter is 100 pm and the depth 
of the microchannel is 50 pm. The total area available for capture is 27.6 mm2. The 
second channel, shown on the right, contains 465 posts, with a post-to-post spacing of 
100 pm, measured edge to edge. The post diameter is 70 pm and the depth of the 
microchannel is 35 pm. The total area available for capture is 26.4 mm2.
5.2.2 Reaction Scheme and Model Assumptions
The purpose of this study is to model the reaction shown in Figure 3-3 inside the 
microchannels. First, the microchip is exposed to UV radiation, carbonizing the pristine 
PMMA. The carbonization places carboxylic acid functional groups on the surface of the 
channel. Then, the carboxylic acid residues are activated using a mixture o f EDC and 
NHS, followed by exposure to oxalyldihydrazide (Figure 2-5) to immobilize the 
crosslinker to the microchannel surface. Lastly, proteins are injected into the channel. 
These proteins are captured by the immobilized oxalyldihydrazide molecules. In this 
chapter, four different oxalyldihydrazide concentrations are modeled: 5 mM, 10 mM,
25 mM, and 50 mM. These concentrations are the same as were used experimentally in 
Chapter 4.
The model protein used is cytochrome c. Cytochrome c is a highly conserved 
protein among many species. The particular molecule used in this paper is equine horse 
heart cytochrome c. It has 104 amino acid residues. It is a membrane associated protein. 
In vivo, it is spherical in shape with a radius of 1.2 nm (Choi and Dimitriadis, 2004).
For the model presented in this paper, certain assumptions are used. These 
assumptions are the following:
1. All PMMA monomers are carbonized during the UV exposure step.
2. The monomers have a 1:1 reaction with oxalyldihydrazide molecules.
3. Oxalyldihydrazide molecules can only react with one UV activated 
PMMA monomer. That is, the molecule cannot bind so that two 
monomers are consumed by the two hydrazide functional groups on one 
oxalyldihydrazide molecule.
4. When oxalyldihydrazide is immobilized on the surface of the 
microchannel, it is immobilized with an even distribution across the unit 
cell. This assumption prevents the model from allowing an area of an 
unsaturated unit cell from being capable of more protein capture than any 
other area o f the unit cell.
5. No capture occurs during loading; all capture occurs during the incubation
5.3 Results and Discussion
5.3.1 PMMA Unit Cell and Oxalyldihydrazide Approximation.
A PMMA unit cell approximation was used for modeling the molecular 
interactions within our microdevice. The PMMA unit cell is 4.196 nm wide, 2.434 nm 
long, and 1.05 nm deep, determined from experimental data (Sane et al., 2002). The unit 
cell contains 150 monomers of the PMMA polymer, arranged in 3 chains of 
50 monomers each. There are a total of 2250 atoms per cell. The unit cell is shown in 
Figure 5-1. There are a total of 3.08 x 1012 and 3.04 x 1012 PMMA unit cells in the lower 
and higher density microchannel, respectively. Therefore, there are a total of 4.63 x 1014 
and 4.56 x 1014 PMMA monomers inside each microchannel, respectively. Using the 
sidearm of the PMMA molecule as a base, the length of the oxalyldihydrazide molecule 
was estimated to be 2.1 nm, based on the molecule having twice as many similarly-sized 
atoms (Figure 2-5). The capture cells within the microchannel are 4.196 nm wide,
2.434 nm long, and 3.15 nm deep, accounting for capture o f oxalyldihydrazide within 
3.15 nm of the channel surface for the model. The capture cell is shown in Figure 5-2. 
The entire channel was divided into equal sized capture cells, with only the cells in 
contact with the wall surface being capable of oxalyldihydrazide and/or protein capture. 
There are a total o f 3.02 x 10!6 and 2.11 x 1016 total cells in the low density and high 
density channels, respectively. Figure 5-3 shows a representation of the cells, with the 
cells capable of capture shown in green.
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Figure 5-1: A schematic of a PMMA unit cell
3.1 nm
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Figure 5-2: Dimensions of the capture cells used in modeling oxalyldihydrazide and 
cytochrome c capture
Figure 5-3: Representation of the arrangement o f capture cells within the microfluidic 
device
Four concentrations of oxalyldihydrazide were used in the model. At these 
concentrations, the number o f oxalyldihydrazide molecules present within a volume of a 
capture cell (32.1 yL) was 67, 134, 334, and 668 for the four concentrations, respectively, 
in the lower density channel. For the higher density channel, the number of 
oxalyldihydrazide molecules was 45, 90, 224, and 448, respectively. These values were 
compared to the available PMMA monomers for reaction (150 monomers) in each 
condition. The results are shown in Figure 5-4.
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Figure 5-4: Ratio of PMMA to oxalyldihydrazide molecules at the four different 
concentrations o f oxalyldihydrazide
By using a ratiometric approach in the analysis, it is easier to determine full 
saturation of the PMMA monomers. Ideally, a concentration that results in an equal 
number o f oxalyldihydrazide to PMMA monomers would be desirable. Above that point, 
as seen in the 5 mM and 10 mM concentrations in both densities, there are unreacted 
PMMA molecules, and the efficiency of the protein capture will not be optimized. Below 
that point, as observed at 25 mM and 50 mM, excessive oxalyldihydrazide will compete 
with bound oxalyldihydrazide for the limited number of PMMA monomers. Therefore, 
once the ratio of PMMA molecules to oxalyldihydrazide molecules decreases below 1, 
reagent usage is no longer optimized.
5.3.2 Binding Energies from DFT
Using DFT, the binding energy between UV activated PMMA and 
oxalyldihydrazide and between oxalyldihydrazide and the four amino acid residues was
determined, according to the reaction scheme seen in Figure 3-3. The binding energy for 
oxalyldihydrazide and UV activated PMMA was -4.47 kcal/mol. The binding energies 
for oxalyldihydrazide reacting with proline, lysine, arginine, and threonine, respectively, 
was -3.06 kcal/mol, -4.00 kcal/mol, -7.80 kcal/mol, and -5.43 kcal/mol. The binding 
energies are presented in Table 5-1.
Table 5-1: Binding energies for PMMA and amino acid residues to oxalyldihydrazide
Phase Binding Energy (kcal/mol)
UV-PMMA to oxalyldihydrazide -4.47
Oxalyldihydrazide to proline -3.06
Oxalyldihydrazide to lysine -4.00
Oxalyldihydrazide to threonine -5.43
Oxalyldihydrazide to arginine -7.80
5.3.3 Protein Binding
In this model, oxidized equine horse heart cytochrome c was used as the target 
protein of interest. Cytochrome c is a highly-conserved protein throughout many 
organisms. It is a spherical protein, with a radius of 1.2 nm, giving it an area o f 4.52 nm2. 
Using this value, 2.2 cytochrome c molecules can attach per unit cell of PMMA. Each 
cytochrome c molecule will occupy the space of 66 PMMA monomers. At the 
concentrations used in this model, per cytochrome c surface area, there will be 
27 oxalyldihydrazide molecules bound at 5 mM, 57 at 10 mM, and 66 at both 25 mM and 
50 mM within the lower density channel. For the higher density channel, the number of 
oxalyldihydrazide molecules is 18, 39, 66, and 66 for each concentration, respectively.
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The oxalyldihydrazide consumption is shown in Figure 5-5. It is assumed in this case 
that after the ratio of PMMA to oxalyldihydrazide molecules decreases below one, the 
PMMA unit cell becomes saturated, and as such, all possible PMMA binding sites are 
occupied with an oxalyldihydrazide molecule.
Eo 60 -
50
40« *Q . g
ea3 f  303 9jj »
O
E
SC9 Xo
20
10  -
♦
□
♦  OxaH molecules/cyto c 
surface area (Low 
Density)
□ OxaH molecules/cyto c 
surface area (High 
Density)
0 10
— i—  
20
— i—
30
— i—
40 50
Oxalyldihdyrazide Concentration (mM)
Figure 5-5: Oxalyldihydrazide molecules per cytochrome c surface area
These values were used to calculate the number of protein molecules captured 
within the chip. For each concentration, a molecule of cytochrome c consumes the 
number of oxalyldihydrazide molecules determined above. Those values were used to 
determine the maximum number of carbonylated proteins that could be enriched in each 
condition. For the lower density channel, 3.12 x 1012, 6.23 x 1012, 7.00 x 1012, and
7.00 x 10^ proteins could be captured for each concentration, respectively. For the 
higher density channel, 2.06 x 1012, 4.22 x 1012, 6.91 x 1012, and 6.91 x 1012 proteins 
could be captured for each concentration, respectively. The results are shown in Figure 
5-6.
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Figure 5-6: Number of proteins captured for each oxalyldihydrazide concentration
After the number of proteins captured was determined, this number was converted 
to a mass. Compared to experimental values found in Chapter 4, the model 
underestimated the experimentally measured values by almost two orders of magnitude. 
The values found using the model and the experimental findings are shown in Table 5-2.
Table 5-2: Comparison of experimental protein capture to predicted capture by the 
model
Concentration Model Results 
(Mg)
Experimental 
Results (pg)
Model Results 
(Mg)
Experimental 
Results (pg)
5 mM 0.06 6.73 0.04 N/A
10 mM 0.12 8.79 0.08 N/A
25 mM 0.14 9.79 0.14 N/A
50 mM 0.14 5.01 0.14 5.18
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The model underestimated the protein capture because it only considered the 
interior o f the microchannel. In order to improve upon these results, the model was 
adjusted to also include the surface area of the reservoirs. Including the reservoirs 
significantly increased the total surface area available for protein capture. Because the 
majority of the experimental data collected in Chapter 4 is for the lower density channel, 
the reservoir consideration was applied to the results of the lower density channel. The 
protein capture for the model’s adjustment is compared to the original model’s results in 
Figure 5-9.
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Figure 5-7: Comparison of protein capture when reservoirs are considered
These protein values were converted to a mass quantity. The model still 
underestimated the amount of proteins found in experimental conditions, but the 
consideration of the surface area contributed by the reservoirs produced a significant 
improvement from the original model’s results. Table 5-3 shows the comparison of the 
protein mass using the new adjustment and the experimental results found in Chapter 4.
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Table 5-3: Comparison of model results to experimental results when the reservoirs are 
considered
Concentration Model Results 
(PR)
Experimental 
Results (pg) Fold difference
5 mM 0.21 6.73 32.0
10 mM 0.42 8.79 20.9
25 mM 0.47 9.79 20.8
50 mM 0.47 5.01 10.6
It is important to consider that volume would be expected to have an impact on 
the protein capture. The PMMA unit cell and the capture cell used in this model have a 
set volume (see Figure 5-2). However, the PMMA unit cell is only present on the 
surface of the microchip (Figure 5-3). Therefore, if the volume of the microchip is 
decreased, more oxalyldihydrazide and proteins would be present within each capture 
cell. The higher concentration of crosslinker and proteins would result in higher capture 
within the microchannel. The lack of a volume consideration probably contributes to the 
underestimation o f the model.
This particular protein has 104 amino acid residues. O f those, there are four 
proline residues, eighteen lysine residues, two arginine residues, and nine threonine 
residues, for a total of 33 possible carbonylation sites. A binding energy of - 
4.51 kcal/mol per binding site is calculated from the weighted average of these residues. 
Because it is impossible to calculate which residue is reacting with the oxalyldihydrazide 
molecule at each point, it is important to consider a weighted average of the amino acid 
residues to get the best approximation. The total binding energy between cytochrome c 
and the oxalyldihydrazide-immobilized PMMA unit cell is 121.7 kcal/mol,
256.8 kcal/mol, 297.4 kcal/mol, and 297.4 kcal/mol, respectively, for the different 
concentrations within the lower density channel. For the higher density channel, the total 
binding energy for the different concentrations are 81.1 kcal/mol, 175.7 kcal/mol,
297.4 kcal/mol, and 297.4 kcal/mol, respectively. The results of this study are shown in 
Figure 5-8.
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Figure 5-8: Energy requirements to break the bond between cytochrome c and 
oxalyldihydrazide at the different oxalyldihydrazide concentrations
The presence of 33 possible binding sites on cytochrome c limits the model. The 
model assumes that every oxalyldihydrazide molecule will bind with cytochrome c. At 
full saturation (25 mM and 50 mM), there are 66 immobilized oxalyldihydrazide 
molecules per cytochrome c surface area. If all possible binding sites on cytochrome c are 
considered, then full saturation occurs at a concentration of oxalyldihydrazide that is 
below 10 mM. However, steric hindrance would prevent additional protein capture 
inside the microchip. It is important to consider this steric hindrance as it will alter the 
binding energy between cytochrome c and the oxalyldihydrazide-immobilized PMMA
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unit cell. This consideration changes the binding energies in the lower density channel to 
121.6 kcal/mol at 5 mM and to 148.7 kcal/mol for the 10 mM, 25 mM, and 50 mM 
concentrations. The higher density channel has a binding energy of 81.1 kcal/mol at 
5 mM and 148.7 kcal/mol for the other concentrations. These results are compared to the 
results that the model gave us in Figure 5-9.
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Figure 5-9: Comparison of the model’s results and the site-limited results
The results here imply a significant change in capture efficiency based on protein 
size. Cytochrome c is a small protein, around 12 kDa. Other proteins are much larger, 
such as bovine serum albumin (BSA), at around 66 kDa. In addition, BSA contains over 
600 amino acid residues, compared to cytochrome c’s 104 residues. With increased size, 
the amount of binding with immobilized oxalyldihydrazide molecules would increase. 
Therefore, the binding energy would be higher for larger proteins as there would be more 
amino acid binding residues. However, the tradeoff in this case would be the limited 
space inside the microchip. Therefore, higher binding energy could be achieved in 
exchange for fewer proteins captured within the microchannel.
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5.3.4 Critical Velocity Calculations
Lastly, Stokes’ Law was used to determine a critical velocity at which these bonds 
between oxalyldihydrazide and the amino acid residues would be broken. First, the 
critical force had to be determined for the oxalyldihydrazide and the cytochrome c 
binding site. This value was calculated to be 6.28 x 10‘6 dynes. The calculation is 
included in this dissertation, beginning with Eq. 5-1:
E
f c = 1.6 X 10‘ 5- .  Eq. 5-1
ro
The E0 value corresponding to a binding energy of 8.5 kcal/mole, the typical 
strength o f an antibody-antigen interaction, is 0.37 eV. Because electron-volts are a 
linear unit, the weighted average binding strength of a binding site on cytochrome c 
(4.51 kcal/mol) correlates to an E0 value of 0.19 eV. As given by Bell (1978), a good 
approximation of r0 is 0.5 nm. Therefore, the calculation continues as follows:
f c =  1.6 x 10"5 x Eq. 5-2
The calculation yields the result/c =  6.28 x 10-6 dynes per bond. This value 
was applied to Stokes’ Law to determine the critical velocity. Because the proteins will 
be delivered in a buffer solution, the viscosity chosen for the calculation is the kinematic 
viscosity o f water at 20 °C (1.002 cP). Using the critical force, a critical velocity of
74.8 m/s at 5 mM and 91.5 m/s at all the other concentrations was obtained for the lower 
density channel. This velocity would be required in order to completely remove the 
protein from the oxalyldihydrazide molecules tethered to the lower density microchannel 
surface.
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The calculation for the 5 mM concentration will be shown below for an example, 
starting with Stokes’ Law (Eq. 5-3):
F =  6nr}rv. Eq. 5-3
First, the total critical force for removing the cytochrome c completely from the 
oxalyldihydrazide molecules immobilizing it is calculated. This value is found by 
multiplying the critical force for each bond by the number of bonds immobilizing the 
protein, shown in Eq. 5-4:
Fc = fcNrAc. Eq. 5-4
NrAc is the number of oxalyldihydrazide molecules per cytochrome c surface
area. For 5 mM, NrAc =  27, as calculated in an earlier section (see Figure 5-5). The
product of the critical force, calculated from Eq. 5-2, and NrAc, yields a total critical 
force of Fc = 1.70 x  10-4 dynes.
Because all of the terms in Stokes’ Law are independent of velocity, substituting 
the total critical force into Eq. 5-3 yields Eq. 5-5:
Fc = 6nr}rvc. Eq. 5-5
Solving for the unknown value, vc, the following calculation can be done:
(1.70 x 1Q-4)(1Q -5)
Vc 6tt(1.002)(1.2 x  10~9)' q'
This calculation gives a critical velocity o f vc =  74.8 m /s .  For the higher density
channel, the critical velocities are 49.9 m/s at the 5 mM concentration and 91.5 m/s at all
the other concentrations. The values used for the calculations are shown in Table 5-4.
91
Table 5-4: Variables used in critical velocity calculations
Variable Definition Value
Eo
The free energy change on 
binding 0.19 eV
ro
The range of the minimum 
work 0.5 nm
r The radius of the binding target 1.2 nm
9
The viscosity o f the 
flowing solution 1.002 cp
One of the assumptions o f this model is that every binding site on the protein can 
and does react with the immobilized oxalyldihydrazide molecules. However, because the 
protein is spherical, it is highly likely that this assumption would not hold in reality.
Many of the binding sites probably are not in contact with the oxalyldihydrazide 
molecule area. Therefore, the number of bonds per protein would be lower than the 
33 bonds it is capable of forming. The fewer the bonds, the lower the critical velocity 
would be to break the bonds. In addition, if more of the bonds are formed using proline 
residues, the binding energy will be lower. Conversely, more bonds with threonine 
residues will result in a higher binding energy. Figure 5-10 shows the range of binding 
energy possible for cytochrome c based upon the number o f bonds formed. Two ways to 
increase the probability o f forming more bonds between cytochrome c and the 
oxalyldihydrazide molecules experimentally would be to reduce the disulfide bonds of 
cystine, which would break some of the turns of the spherical protein, and denaturing the 
protein using heat and/or extreme pH conditions. However, such an approach would 
have a tradeoff as the denatured protein would consume a larger area. Therefore, higher 
binding energy would be possible at the expense of fewer proteins being captured.
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Figure 5-10: The maximum and minimum binding energies possible based on the 
number of bonds formed
Using the least favorable conditions for binding energy (1 proline residue bond 
formed), a critical velocity for breaking this bond would be 1.88 m/s, a 1000-fold higher 
than experimental loading conditions. In a microfluidic environment, the likelihood of 
the bonds breaking because they exceed the critical velocity is low. At the rates 
necessary to break the bonds, even at the least favorable condition, the pressure drop 
within the microchannel would be insurmountable. Therefore, microdevice failure is 
more likely to be caused by the breaking of a seal than by the breaking of the bonds 
breaking inside the channels.
In this chapter, a theoretical modeling approach geared toward optimizing 
enrichment of carbonylated proteins within a microfluidic device was presented. Two 
interior chip geometries were used. The model generated the binding energy between 
oxalyldihydrazide and PMMA, as well as the binding energy between oxalyldihydrazide
5.4 Conclusions
and select amino acid residues. A total binding energy of cytochrome c with the 
immobilized oxalyldihydrazide molecules was found. Lastly, Stokes’ law was used to 
calculate the critical velocity that would result in the breaking of the chemical bonds. It 
was determined theoretically that flow conditions will not cause the microfluidic 
enrichment technique to fail, as the flow velocities needed to dissociate the bonds exceed 
feasible flow velocities within a microdevice.
The model provides guidance toward the optimization of the novel enrichment 
methodology. However, the model has a few limitations. The assumptions o f the model 
represent an ideal environment. The model does not consider reactions that occur during 
protein loading. Lastly, when the number of proteins captured is converted to a mass 
quantity, it was found that the model underestimated the experimentally determined mass 
in Chapter 4 by over an order of magnitude. In the next chapter, suggestions for 
improving the model will be discussed.
CHAPTER 6
CONCLUSIONS AND FUTURE WORK
6.1 Conclusions
The development of a novel enrichment technology for carbonylated proteins has 
been discussed. Advantages of using this system to the conventional technique of affinity 
column chromatography include reduced sample consumption, reduced time, and 
minimized sample preparation steps. These advantages are outlined in Table 6-1.
Because the process is done on a microfluidic platform, experiments can easily be nm in 
parallel in order to achieve high-throughput protein analysis. When proteins are eluted 
from this system, they are readily available for additional analysis, such as mass 
spectroscopy or electrophoresis. Because samples do not require derivatization prior to 
loading into the microchip, no additional considerations, such as molecular weight shift, 
need to be taken when the samples are analyzed further.
This microfluidic technique is used for positive enrichment of carbonylated 
proteins. The technique could also be used for negative enrichment o f carbonylated 
proteins; in case these low abundance proteins are not desirable in a sample o f interest.
In addition, because of the ease o f modifying the surface of PMMA, the technique can be 
modified for analyzing other protein modifications present in diseased state tissue. An 
important feature of this process is its versatility. While oxalyldihydrazide was used in 
this study for carbonylated protein enrichment, other crosslinkers can be used for other
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post-translational modifications. Because of its versatility, the technique has potential for 
applications in both basic and clinical sciences.
The microfluidic enrichment technique provides a promising platform for 
carbonylated protein biomarker discovery in conditions where carbonylated proteins have 
been implicated. This device can provide a stepping stone in the development o f novel 
diagnostic technologies making use o f biomarkers. It has the ability to be at the forefront 
of quantitative biomarker discovery in conditions such as Alzheimer’s Disease, ALS, and 
other neurodegenerative diseases. The technique is an attractive alternative to the 
conventionally used avidin affinity chromatography. Because it is microfluidic-based, it 
consumes little benchtop space. The technique can provide the building blocks for a 
clinically-translatable technology that can yield a quick result on the diagnosis of 
neurodegenerative diseases. The process is highly automated, therefore little training 
would be required on the part of a clinician to use it and get a result. In addition, because 
it is polymer-based, it is disposable and reduces the chance for cross-contamination 
between samples. The high versatility of the technique grants a wide range of 
applications in both basic and clinical sciences.
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Table 6-1: Comparison between the enrichment technology in different phases and 
avidin affinity chromatography
Category Phase 1 Enrichment
Phase 2 
Enrichment
Avidin Affinity 
Chromatography
Time Requirement 20 hours 4.5 hours 18 hours
Sample
Requirement 100 pg 40 pg 10 mg
Reagent
Requirement
50 mM crosslinker 
for immobilization
25 mM crosslinker 
for immobilization
Already packaged, 
not determinable
Elution Volume 15 pL 15 pL 4 column volumes (> 12 mL)
Minimum sample 
size > 1 Mg > 1 Mg > 4 m L
Need for 
Derivatization No No Yes
6.2 Future Work
6.2.1 High-throughput Chip Design
The technique discussed in this dissertation produced a preconcentration factor of 
2.65. This number depends on the concentration of proteins in a sample. In a clinical 
sample, where concentration is much lower than our experimental conditions, the 
preconcentration factor will be greatly enhanced. However, the chip design would need 
to be changed to allow for high-throughput analysis. Without such an adjustment, the 
time advantages offered by the technique would be sacrificed. A simple change to the 
design that would increase its high-throughput abilities would be to place numerous 
channels on a chip, allowing for a sample to be run in parallel.
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6.2.2 Enrichment of Multiple Proteins on a Single Microfluidic Device
Since the capture process has been optimized, future directions involve studying 
the enrichment behavior o f the chip when multiple carbonylated proteins are present. In 
all the studies discussed in this dissertation, only one carbonylated protein has been 
present in a sample. However, as discussed in Chapter 5, the binding characteristics o f 
proteins vary greatly depending upon their size and amino acid sequence. Therefore, it 
would be important to analyze the capture ability of the device when using multiple 
carbonylated proteins within one sample. A good approach to this analysis would be the 
use of protein standards of different sizes. The proteins could be labeled with different 
fluorescent tags, and capture could be analyzed using the methods described in this 
dissertation. However, a better approach may be to couple the microchip to a standard 
benchtop analytical technique, such as capillary electrophoresis, to determine the 
technique’s ability to enrich multiple carbonylated proteins. While this approach lacks 
the quantitative ability of the fluorescence approach used in this dissertation, the 
experiment will be less costly because each protein in the sample could be derivatized 
with the same fluorophore. To use the fluorescence technique described in this 
dissertation, each protein in the sample would require the use of a unique fluorophore.
The fluorophores would need to have similar excitation wavelengths, but different 
emission wavelengths. However, excitation and emission wavelengths tend to be 
correlated for different fluorophores. For example, few fluorescence agents absorb at 
488 nm and emit at a wavelength other than 514 nm. If each fluorescent tag were probed 
at a different time point, valuable data could be lost and interpolation would be required,
98
reducing the reliability of the data. Therefore, coupling the microchip to a technique like 
electrophoresis will yield more reliable results, with a decreased quantitative ability.
6.2.3 Use of a Biological Sample on the Microdevice
In addition, biological samples need to be examined in future work. Such a 
sample would be the most complicated sample tested on the microchip. However, the 
true power o f the technique will only be seen when a biological sample is used. As an 
example, brain tissue could be homogenized, redissolved in a buffer, and then introduced 
into the microdevice, to determine whether the carbonylated proteins are detected. For 
this study, the proteins would not be labeled with fluorescent agents. Post-elution, the 
sample would be passed to another analytical technique to identify and detect protein 
targets.
6.2.4 Coupling the Microdevice for Protein Identification
The microfluidic enrichment technique, as developed, was never intended to be a
stand-alone device in its current form. Figure 6-1 shows the modular approach toward
protein enrichment, detection, and identification. As can be seen, the microfluidic 
enrichment technique is only a first step in the process. The microdevice will need to be 
coupled with a technique for identification of targets. Good candidates for coupling 
include capillary electrophoresis (conventional or microfluidic) or mass spectroscopy. 
Capillary electrophoresis is more promising as a coupling technology than traditional gel 
electrophoresis because it possesses some quantitative aspects. Capillary electrophoresis 
is a technique used for separating analytes within a solution (Feng et al., 2008). If 
capillary electrophoresis is coupled to laser-induced fluorescence, detection of analytes 
can be done following a fluorescence derivatization. Samples are loaded into a capillary
via hydrodynamic pressure. A charge is applied through the sample and the entire bulk 
of the sample moves toward the charge. Molecules are separated based upon size to 
charge (m/z) ratio. Molecules that are similarly charged to the bulk move more rapidly, 
while molecules with an opposite charge of the bulk migrate more slowly. Neutral- 
charged molecules move at the same pace as the bulk. If two molecules have a similar 
charge, larger molecules migrate more quickly. Relative carbonylation can be quantified 
using wide peak analysis. A standard setup for capillary electrophoresis is shown in 
Figure 6-2.
Microfluidic capillary electrophoresis uses the same principles as standard 
capillary electrophoresis (Wang et al., 2012). Microfluidic capillary electrophoresis is 
more attractive as a coupling technique than standard capillary electrophoresis because 
the enrichment technique is also microfluidic-based. A typical setup for microfluidic 
capillary electrophoresis is shown in Figure 6-3. The small volume eluted from the 
microfluidic enrichment technique (15 pL) would be complementary to the sample 
requirements for microfluidic capillary electrophoresis, as opposed to the higher 
volumetric requirements for standard capillary electrophoresis (100 pL). The elution 
volume is within the acceptable range for mass spectroscopy, which would be used to 
identify the proteins that are eluted from the microdevice. With identification, 
carbonylated proteins can be associated with different pathways and progress can be 
made toward identifying potential carbonylated protein therapeutic targets. Also, in the 
future, it may be possible to do an on-line coupling of the device to one of the techniques 
mentioned above.
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Figure 6-1: Modular approach towards carbonylated protein biomarker discovery
Figure 6-2: Classic setup for capillary electrophoresis. After the sample is loaded into 
the capillary using hydrodynamic pressure, a charge is applied to the sample. 
Molecules migrate through the channel based upon size to charge (m/z) ratio. Neutral 
charged molecules move at the same pace as the bulk solution. Larger molecules with 
the opposite charge of the bulk solution migrate at a slower pace than smaller, 
oppositely charged molecules. Larger molecules with the same charge as the bulk 
solution migrate faster than smaller, similarly charged molecules.
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Figure 6-3: Instrumentation for microfluidic capillary electrophoresis
6.3.1
6.3 M ethod Improvements
Pulsed Flow vs. Continuous Flow
Biological samples, such as blood, cerebrospinal fluid, or plasma, are precious. 
Other biological samples, such as urine or saliva, are more available and require less 
invasive methods for obtaining them. Regardless of the availability of the sample or the 
invasiveness of the method to collect it, the most optimal method for protein capture 
(including both protein capture and time requirement) must be employed. In all the 
studies described in this dissertation, a continuous flow injection was used, followed by 
an incubation period. This procedure exposes the device to a large amount of proteins. 
Use of a pulsed flow may provide enhanced protein capture over a shorter time frame. A 
flow rate duty cycle will allow proteins increased contact time during the loading cycle.
1 0 2
As stated in Chapter 4, an increased contact time allows for more bonds to be formed. A 
50 % duty cycle (five minutes on, five minutes off), may allow experiments completed in 
40 minutes of continuous injections to be completed in two cycles. In the first cycle,
5 pg of proteins (assuming optimal conditions determined in Chapter 4) would be 
injected into the channel and then allowed to have contact time in a stationary flow field. 
The second cycle, also 5 pg, would be injected to fill any capture areas not already 
occupied by proteins from the first cycle. After 20 minutes, 10 pg of proteins would 
have been exposed to the device. This mass amount is the near the upper limit of proteins 
captured during the optimization process.
6.3.2 BioMEMS vs. BioNEMS
BioMEMS is an emerging technology for on-chip cell cultures. This technology 
is a great platform for cell studies because the dimensions are on the same scale as cells, 
as the average animal cell diameter is 10 pm. For protein work, however, the scale may 
be too large. As shown in Figure 5-3 and discussed in Chapter 5, much of the space 
within the microchip is not usable for protein enrichment. A viable alternative 
technology is Biological Nano-Electromechanical Systems, or BioNEMS. Nano­
electromechanical systems (NEMS) incorporate mechanical and electrical components on 
the nanometer scale. BioNEMS is the use o f NEMS for biological applications, such as 
the one discussed in this dissertation. These chips could be constructed using electron- 
beam lithography, or EBL, that can create structures on the order of sub-100 nm range 
(Hao et al., 2010), more in line with the size o f proteins. EBL has been used on PMMA 
substrates to form complex nanostructures (Gautsch et al., 2010). Therefore, moving the 
enrichment technique from a microfluidic platform to a nanofluidic platform has merit.
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One issue that would need to be considered in this leap from micro to nano would
be overcoming the increased pressure drop. Pressure drop in microfluidic channels have
been studied by numerous groups (Fuerstman et al., 2007; Akbari et al., 2009; Vanapalli
et al., 2007). For a rectangular channel, the equation for pressure drop is given as:
afiQL _  ^ ,
AP = -------. Eq. 6-1
W H 3 M
For any rectangular channel where the aspect ratio (W/ H)  is below 1, and the 
Reynolds number is below 1000, Eq. 6-1 is accurate to within 0.26 %.  The above 
equation demonstrates the challenge that comes with the transition from micro to nano.
In order to have sufficient capture, the channel will either have to be longer than the 
current format (L increases), shorter in width (W decreases), or more shallow in depth 
(H decreases). Any one of these changes will increase the pressure drop. Therefore, a 
successful transition to BioNEMS would require a design change toward higher- 
throughput capability.
One group has suggested a method of microfluidic device design that would 
minimize pressure drop (Yeom et al., 2009). They propose a figure-of-merit (FOM) that 
optimizes surface area and volume of the device so that the functionality of the device is 
maximized while the pressure drop is minimized. The use of a FOM analysis on the 
nanofluidic device may assist in the development of a system that is not overcome by the 
pressure drop.
6.3.3 Modeling the Flux of Oxalyldihydrazide and Proteins
The current model ignores reactions during the injection flow. Knowledge of 
mass transport through the chip would be beneficial. As seen in Figure 5-3, there are 
many cells within the channel that are not capable of capturing oxalyldihydrazide or
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proteins. However, it is assumed that the oxalyldihydrazide is dispersed evenly through 
the microchip, with an equal amount o f oxalyldihydrazide and proteins in each cell o f the 
chip. Because oxalyldihydrazide is only captured on the cells that contact the surface of 
the microchannel, the molecules traveling in the innermost cells must migrate toward the 
wall. The flux could be determined in three dimensions from a series o f one- 
compartment models.
6.3.4 Modeling Concentration Changes throughout the Chip
In addition to flux changes, concentration changes throughout the chip can be 
modeled with fluid dynamics software, such as COMSOL. The software modeling can 
perform the flux calculations needed and generate a visual representation of the 
concentration changes inside the microchip. Figure 6-4 shows a representative example 
of the expected results from such modeling, showing the anticipated profiles at different 
locations along the x-axis. Figure 6-5 shows the expected concentration profiles along 
the x-axis.
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Figure 6-5: Anticipated concentration profiles along the x-axis o f the microfluidic 
device
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6.3.5 Modeling Protein Capture under Flowing Conditions
The model was designed to predict protein capture. When the number of proteins 
captured was converted to a mass quantity, the mass was over an order of magnitude 
below the experimentally determined values in Chapter 4. This difference implies that 
the reactions that take place during the crosslinker loading and protein loading are not 
insignificant. In fact, binding kinetics should be considered in future experiments, as 
well as possible protein orientation inside the microchip.
APPENDIX
ADDITIONAL INFORMATION ON THE AMINO ACIDS
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The structures, abbreviations, chemical properties, and possible oxidative 
modifications of the amino acids are given in this appendix. The pi and pKa values were 
obtained from Carey (2011). The oxidative modifications that are possible are found in 
Madian and Regnier (2010).
ALANINE (Ala, A)
-Group: Neutral, non­
polar
-pi: 6.00
-pKa: N/A
-Oxidation modification:
None
OH
CH
O
N hf^N H
ARGININE (Arg, R) 
-Group: Basic, polar 
-pi: 10.76 
-pKa: 12.48
-Oxidation modification: 
glutamic semialdehyde
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ASPARAGINE (Asn, N) 
-Group: Neutral, polar 
-pi: 5.41 
-pKa: N/A
-Oxidation modification: 
hydroxylation
ASPARTIC ACID (Asp, D) 
-Group: Acidic, polar 
-pi: 2.77 
-pKa: 3.55
-Oxidation modifications: 
hydroxylation
CYSTEINE (Cys, C)
-Group: Neutral, polar 
-pi: 5.07 
-pKa: N/A
-Oxidation modifications: 
cysteic acid, sulfinic acid, 
sulfenic acid, 
hydroxynonenal (HNE) 
Michael adduct
GLUTAMIC ACID (Glu, E)
-Group: Acidic, polar
-pi: 3.22
-pKa: 4.25
O -Oxidation modification: 
None
GLUTAMINE {Gin, Q)
-Group: Neutral, polar
2 -pi: 5.65
-pKa: N/A
O -Oxidation modification: 
None
GLYCINE (Gly, G)
-Group: Neutral, non­
polar
-pi: 5.97
-pKa: N/A
-Oxidation modification: 
None
I l l
OH
O
NH
HISTIDINE (His, H) 
-Group: Basic, polar 
-pi: 7.59 
-pKa: 6.00
-Oxidation modifications: 
4-hydroxy glutamate, 
asparagine, aspartate, 2- 
oxo-histidine, 
hydroxynonenal (HNE) 
Michael adduct
OH CH
CH
O
NH
ISOLEUCINE (lie, I)
-Group: Neutral, non­
polar
-pi: 6.02
-pKa: N/A
-Oxidation modification: 
None
OH
CH
O
LEUCINE (Leu, L)
-Group: Neutral, non­
polar
-pi: 5.98
-pKa: N/A
-Oxidation modification: 
hydroxyleucine
LYSINE (Lys, K)
-Group: Basic, polar
-pi: 9.74
-pIC,: 10.53
NH2 -Oxidation modifications: 
aminoadipic semialdehyde, 
Amadort adduct, 3- 
deoxyglucosone adduct, 
glyoxal adduct, methylglyoxal 
adduct, hydroxylation, 
hydroxynonenal (HNE) 
Michael adduct, 
malondialdehyde
METHIONINE (Met, M)
-Group: Neutral, non­
polar
-Pi: 5.74  
CH3 -PKa: N/A
-Oxidation modifications: 
sulfoxide, sulfone
PHENYLALANINE (Phe, F)
-Group: Neutral, non­
polar
-pi: 5.48
-pKa: N/A
-Oxidation modifications:
hydroxylation,
dihydroxyphenylalanine
PROLINE (Pro, P)
-Group: Neutral, non- 
OH polar
-pi: 6.30 
-pKa: N/A
-Oxidation modifications 
hydroxylation, glutamic 
semialdehyde, 
pyroglutamic acid, 
pyrrolidinone
SERINE (Ser, S)
-Group: Neutral, polar 
-pi: 5.68 
-pKa: N/A
-Oxidation modification: 
None 
NH2
OH CH
OH
N H '
THREONINE (Thr, T) 
-Group: Neutral, polar 
-pi: 5.60 
-pKa: N/A
-Oxidation modification: 
2-amino-3-oxo-butanoic 
acid
'N '
H
TRYPTOPHAN (Trp, W) 
-Group: Neutral, polar 
-pi: 5.89 
-pKa: N/A
-Oxidation modifications: 
formylkynurenin, 
kynurenin, 2,4,5,6,7 
hydroxylation of 
trytophan, oxolactone
'OH
TYROSINE (Tyr, Y) 
-Group: Neutral, polar 
-pi: 5.66 
-pKa: N/A
-Oxidation modification: 
hydroxylation
VALINE (Val, V)
-Group: Neutral, non­
polar
-pi: 5.96
-pKa: N/A
-Oxidation modification: 
None
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